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Glossary
Chemsex The use of specific drugs before or during planned sex to facilitate, initiate, prolong, 
sustain and intensify the encounter. 
Intercourse In this survey, we use ‘intercourse’ to mean sex where one partner puts their penis into 
the other partner’s anus or vagina, whether or not this occurs to ejaculation. Intercourse 
does not include oral sex or the use of dildos.
n= The number of respondents represented.
Non-steady male partner This refers to any partner with whom men have had sex with once only, and men they 
have sex with more than once but who they do not think of as a steady partner (this 
includes one-night stands, anonymous and casual partners, and regular sex buddies).
PEP is a medicine taken very soon after exposure (or possible exposure) to HIV to prevent 
HIV transmission.
PrEP is a medication taken before exposure or possible exposure to HIV to prevent HIV 
transmission.
Serosorting The practice of using HIV status as a decision-making point in choosing sexual 
behaviour.
Sex In this survey, we use the term ‘sex’ to mean physical contact to orgasm (or close to 
orgasm) for one or both partners. 
Significant This is a statistical term used to denote how likely a finding is to have occurred by chance. 
Steady male partner Refers to boyfriends or husbands that mean they are not single, but not to partners 
who are simply sex buddies.
Syndemic A set of linked health problems involving two or more diseases, interacting together, 
and contributing to excess burden of disease in a population.
Trans man A trans man (sometimes trans-man or transman) is a transgender person who was 
assigned female sex at birth but whose gender identity is that of a man.
Variable Any characteristics, number, or quantity that can be measured or counted.
Viral load Used to describe the amount of HIV in a body fluid, depending on the applied 
laboratory technology.
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Chapter 1 Introduction
EMIS-2017 (European Men Who Have Sex with Men Internet Survey-2017) was part of ESTICOM (European 
surveys and training to improve men who have sex with men community health) and was funded by the European 
Commission Health Programme 2015–2020. The overall aim of EMIS-2017 was to generate data useful for the 
planning of Human Immunodeficiency Virus (HIV) and sexually transmitted infection (STI) prevention and care 
programmes, and the monitoring of progress in this area by:
•	 describing	the	level	and	distribution	of	HIV	transmission	risk	and	precautionary	behaviours	
•	 describing	related	HIV	prevention	needs
•	 assessing	self-reported	STI	testing	behaviours,	and	various	STI	diagnoses,	including	viral	hepatitis.	
Data were provided by Sigma Research, London School of Hygiene and Tropical Medicine (LSHTM), the EMIS-
2017 co-ordinator, on eligible respondents who were living in Ireland at the time of the survey for a national 
descriptive analysis of EMIS-2017 data for Ireland. 
In Ireland and elsewhere, HIV and STIs disproportionately affect men who have sex with men (MSM). In 2017, 
there were 492 HIV notifications in Ireland, a rate of 10.3 per 100,000 population. Overall, the rate of HIV 
diagnoses has been stable between 2015 and 2017, with a slight decrease (2%) between 2016 and 2017.1 Ireland 
has a concentrated HIV epidemic, with infections mainly occurring in MSM, in migrants from a country of high 
endemicity and in people who inject drugs (PWID). By transmission route, MSM are the population most affected 
by HIV in Ireland. In all, 53% of HIV diagnoses in 2017 were in MSM. Among MSM, 42% of cases in 2017 had 
been previously diagnosed abroad.1 This pattern is becoming more common, as increasing proportions of new 
diagnoses in Ireland in all risk groups are already diagnosed abroad before their first diagnosis in Ireland. 
Other STIs remain common among MSM in Ireland. Rates of early infectious syphilis (EIS), gonorrhoea, hepatitis 
A and hepatitis C in MSM increased in 2017 compared to the previous year.2, 3, 4, 5 Notifications of EIS have 
been increasing steadily since 2012, and gonorrhoea has been increasing since 2009. In 2017, MSM were the 
population most affected by EIS, lymphogranuloma venereum (LGV), gonorrhoea and hepatitis A.2, 3, 4, 6 For 
hepatitis C, nearly two-thirds (65%) of the 17 cases who identified as MSM in 2017 were HIV positive at the time 
of hepatitis C diagnosis.5 
MSM continue to be a key group at risk of HIV transmission. Policy makers in education, health and social 
inclusion, clinicians, community-based and voluntary sector organisations, all require accurate and up-to-date 
information on knowledge, attitudes, needs and behaviours in order to design, fund and implement HIV and STI 
prevention interventions for gay, bisexual and other MSM in Ireland. 
A number of previous surveys on knowledge, attitudes, needs and behaviours of MSM have been carried out 
in Ireland. On initiation of a partnership by Gay Health Network (GHN), the Gay Men’s Sex Survey (GMSS) was 
carried out by Sigma Research and included MSM in Ireland from 2000–2008.7, 8, 9 More recent surveys conducted 
in Ireland include: EMIS-2010 and the MSM Internet Survey Ireland (MISI) 2015.10, 11 EMIS-2010 was a survey of 
more than 180,000 MSM living in Europe, including 2,037 men living in Ireland. The EMIS-2010 findings for Ireland 
were used to inform the development of the joint Health Service Executive (HSE) and GHN first National Sexual 
Health and HIV awareness programme for MSM (www.man2man.ie). MISI 2015 was an Ireland-only based survey 
and was run by a multi-sectorial partnership of GHN, Gay Men’s Health Service (GMHS), Sexual Health and Crisis 
Pregnancy Programme (SHCPP) and the Health Protection Surveillance Centre (HPSC), supported by a group of 
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international experts. MISI provided important information which allowed for tailored prevention interventions for 
the MSM population in Ireland. These surveys were paramount in tracking up-to-date behavioural trends and were 
key to informing resource allocation and service planning.
1.1 EMIS-2017 Ireland
The EMIS-2017 Ireland project was funded by SHCPP, and was supported by a steering group of national and 
international partners. 
The overall objectives of EMIS-2017 Ireland were to:
•	 assess	reported	ill	health	in	MSM,	including	markers	of	mental	health	and	HIV/STI	diagnoses	
•	 describe	risk	and	precautionary	behaviours	engaged	in	by	MSM	in	Ireland
•	 identify	needs	in	the	MSM	community,	including	safer	sex,	post-exposure	prophylaxis	(PEP)	and	pre-exposure	
prophylaxis (PrEP) use and HIV testing and treatment 
•	 monitor	the	use	of	interventions	intended	to	reduce	HIV	and	STI	needs.
This report presents an overview of the main findings from the EMIS-2017 Ireland dataset. 
Chapter 2 describes the methodology used to undertake EMIS-2017 and the analysis of the EMIS-2017 Ireland 
dataset. Chapters 3 to 7 explore a number of thematic issues and investigate some key questions in more depth. 
Chapter 8 discusses the importance of the findings in an Irish context and chapter 9 makes recommendations for 
key areas for action and research for MSM in Ireland.
The results of the survey are described throughout the following chapters:
•	 Chapter 3 Demographic profile
•	 Chapter 4 Reported ill health: This chapter describes reported physical and mental ill health by MSM, and 
may be of particular interest to healthcare providers and those planning health services for MSM, and services 
to cater for MSM morbidities. 
•	 Chapter 5 Risk and precautionary behaviours: This chapter reports on risk behaviours and precautionary 
behaviours reported by MSM, and may be of particular interest to those involved in planning, implementing 
and monitoring interventions to reduce risk behaviours and enable precautionary behaviours. There is also a 
section that reviews behaviours during last sex session in more detail. 
•	 Chapter 6 Needs: This chapter identifies the needs of MSM that, if addressed, may lead to better engagement 
in precautionary sexual health behaviours and the avoidance of risk behaviours. This chapter may be of 
particular interest to statutory and non-governmental organisation (NGO) health promotion service providers 
who are planning, implementing and monitoring interventions.
•	 Chapter 7 Interventions: This chapter is aimed at those who plan, deliver and evaluate interventions and 
outlines the types of interventions that can influence needs, such as homophobic abuse or access to services.
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Chapter 2 Survey design and methods
This chapter provides information on the methodology used in the design, delivery and promotion of EMIS-2017. 
It describes the final Irish sample prior to the analysis presented in the remainder of the report. 
2.1 Survey development
EMIS-2017 was an online, behavioural surveillance survey designed to collect data from MSM living in 50 
countries and included all 28 member states of the European Union (EU). Other countries in Europe and outside 
Europe were also involved. It was an anonymous, self-reported, cross-sectional survey.
EMIS-2017 was adapted from the EMIS-2010 cross-sectional questionnaire.10 Questions from EMIS-2010 that 
generated little interest were omitted, and new questions were added based on interest generated by recent 
developments in the area, e.g. PrEP and chemsex. 
The survey was piloted by five health promotion agencies in the UK working with MSM. Following the pilot, the 
language, content and layout of the survey were amended as necessary. The final survey sought up to 409 data 
items from respondents. However, very few men were asked all questions, as the survey used intra-questionnaire 
filters wherever possible. Ethical approval for this study was obtained from the Observational Research Ethics 
Committee at the LSHTM (review reference 14421 /RR/8805).  An important feature of this ethical approval was 
that local ethical approval was not required from the countries within which participants were recruited given that 
it was classified as a UK based survey.
2.2 Recruitment procedures
EMIS-2017 had a soft launch on the week beginning 12 October 2017 with very limited promotion; this was done 
in order to test the online systems. The survey officially began on 19 October 2017 and finished on 30 January 
2018.
EMIS-2017 in Ireland was promoted on a number of platforms, including:
•	 national	statutory	and	NGO	websites	for	MSM
•	 social	networking	sites	(such	as	Facebook,	Twitter	and	Instagram)	
•	 geo-spatial	sexual	contact	smartphone	applications	(apps)	and	websites.
The EMIS-2017 study co-ordinators commissioned advertising on several dating platform apps that were used by 
MSM in each country. In Ireland, the EMIS-2017 survey was advertised on: PlanetRomeo, Grindr, Hornet, Recon, 
Scruff, Gaydar, Manhunt/Jack’d and GROWLr.
A multi-disciplinary communication subgroup for EMIS-2017 Ireland was formed in August 2017, led by GHN. The 
group was tasked with promotion of EMIS-2017 in Ireland. Information relating to the survey was disseminated to 
a number of statutory and NGO bodies for advertisement on their websites and social media. In addition, over the 
duration of the recruitment period, adverts were published in Gay Community News (GCN), which is a national, 
monthly, free publication. A press release was organised in the latter half of the recruitment period which involved 
a photoshoot in a popular gay bar in Dublin. This press release was covered in GCN as shown in Figure 2.1. With 
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regard to ‘offline’ promotion, posters and business cards were distributed at gay social and community venues, 
and services. 
All promotion of EMIS-2017, whether paid or unpaid, included a unique ’source code’ embedded at the end of the 
Uniform Resource Locator (URL). This allowed researchers to track the source of recruitment for each respondent 
and allowed the EMIS-2017 co-ordinators to monitor advertising success (and failure) on a daily basis and make 
adjustments to the strategy as required.
Figure 2.1 Promotional advert for EMIS-2017 in national community publication in Ireland (Gay Community 
News, 19 January 2018)
2.3 Inclusion criteria for EMIS-2017 Ireland
2.3.1 For the EMIS-2017 survey
Respondents had to indicate that they wished to take part in the EMIS-2017 survey by confirming that they had 
read and understood the nature and purpose of the study. Qualification criteria also included that they were at or 
over the age of sexual consent in the country in which they lived (17 years in Ireland), and that they identified as a 
man or trans man and that they were sexually attracted to men and/or were currently or previously sexually active 
with men. 
2.3.2 For this report
Respondents who indicated that they lived in Ireland were included in the Irish dataset. All qualifying respondents 
included in the dataset were analysed for this report. In several places, the questionnaire allowed logically 
inconsistent data to be supplied, where answers to two questions could not both be valid. Three discrepancy 
flags were created to indicate whether a respondent had supplied inconsistent data in the following three 
areas: age, steady partners, and non-steady partners. Overall, 200 respondents (9.6%) in the Irish dataset had 
discrepant data in one or more of these three areas. The overall European report did not exclude discrepant data 
in their analysis and, given the descriptive nature of this report, we did not exclude any cases on the basis of 
discrepancies. 
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2.4 Participation 
There were 2,106 consenting respondents from Ireland. Twenty-three (1.1%) respondents did not meet the 
criteria for inclusion. Two indicated they were not a man or a trans man, 13 indicated they had no evidence of 
homosexual desire or behaviour and eight were below the age of consent or did not indicate their age. Overall, 
2,083 qualifying respondents were included in the Irish dataset. The majority of respondents (32%) were directed 
to the survey from Grindr, 18% from social media channels (Facebook, Twitter or Instagram), and 18% from other 
local methods of recruitment including national websites (Table 2.1). 
Table 2.1 Source of recruitment (n=2,083)
Source of recruitment n %
Grindr 670 32.2
National websites 368 17.7
Facebook, Twitter, Instagram 366 17.6
Unknown source code 297 14.3
Other dating apps 182 8.7
Planet Romeo 98 4.7
Hornet 99 4.7
Softstart 3 0.1
The highest number of respondents recruited in a single week was 290 in week 13 (11 January to 17 January). 
This was in response to the press release organised by the EMIS-2017 Ireland communications group. There were 
periodic increases in the numbers who completed the survey in the latter half of the study. 
Smartphones were the most popular method of accessing the EMIS-2017 survey in Ireland (79%), followed by 
desktop (17%) and a tablet device (5%). It took respondents an average of 29 minutes to complete the survey.
Figure 2.2 Number of survey respondents by week of recruitment from 12 October 2017 to 31 January 2018
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2.5 Languages used for survey completion
Respondents had a choice of 33 languages in which to complete the survey. Twenty-five languages were used to 
complete the survey in Ireland. 
Ninety-two percent of respondents used English to complete the survey. Among the 8% of respondents who 
used a language other than English to complete the survey (n=162), the most commonly used languages were 
Portuguese (23%), Spanish (20%) and Italian (10%). 
2.6 Data analysis
The survey data were extracted from Demographix and imported into SPSS by Sigma Research at LHSTM. The 
data were cleaned and recoded. The data were transferred to the EMIS-2017 Ireland research group in October 
2018 and imported into STATA where they were further recoded and analysed for this report. The likelihood that 
differences among individuals in different groups were due to chance was established using chi-squared analysis 
(c2), independent t-test or analysis of variance (ANOVA) where appropriate. A 5% (p ≤0.05) level of significance 
was applied.
It was not mandatory to answer all questions in the survey and therefore the tables and figures presented in this 
report are the valid responses for each question, that is, they exclude people who did not answer that particular 
question. Percentages are provided to one decimal place in the tables. Percentages in the text are rounded up to 
the nearest integer. 
2.7 Strengths and limitations
Strengths and limitations of the EMIS-2017 survey are listed in Table 2.2.
Table 2.2 Strengths and limitations of the survey
Strengths Limitations
Built on the experience of previous surveys, 
including EMIS-2010
•	Convenience	sample
•	Self-reported	survey
•	Cross-sectional	survey	and	therefore	cannot	conclude	that	any	
relationships observed are causal 
Large sample size which facilitates the analysis 
of subgroups
Long completion time among Irish respondents – 29 minutes
Number of recruitment methods used, 
including offline promotion in club/bar 
washrooms and health services for MSM
Multiple comparison analysis was used to compare indicators by key 
characteristics – increased chance of false positives
Survey available in 33 languages Weaknesses in some survey questions:
•	Non-standardised	measure	of	alcohol	and	tobacco	consumption
•	Scales	used	for	sexual	happiness	and	thoughts	of	harm	or	better	off	
dead not validated in this population
Broad geographical coverage across Ireland Difficulties in comparing prevalence of chemsex in EMIS-2017 Ireland 
to other surveys in the Irish context due to variance in the definition of 
chemsex
Broad range of topics included
10
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Chapter 3 Demographic profile
3.1 Gender identity
Two thousand and eighty-three men were included in the final analytic sample. Fewer than 1% (n=17) of 
respondents identified as a trans man.
3.2 Age 
Age was a qualifying condition for the survey, i.e. being at or above the age of consent for sex in Ireland (17 years 
and older). Figure 3.1 shows the distribution of age across the entire sample. 
Figure 3.1 Age distribution of respondents (n=2,083)
The median age of respondents was 33 years (range 17 to 74 years) and the average was 35 years. Twenty-three 
percent of respondents (n=469) were young people aged 17–24 years and 8% (n=162) were 55 years or older 
(Table 3.1). 
Table 3.1 Distribution of respondents by age group (n=2,083)
Age group (years) n % Cumulative %
17-24 469 22.5 22.5
25–39 968 46.5 69.0
40–54 484 23.2 92.2
≥55 162 7.8 100.0
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3.3 County of residence and settlement size
There were respondents from all 26 counties in the Republic of Ireland. One hundred and twenty-one men 
(6%) did not provide their county of residence. More than half the respondents were living in Dublin (57%), 9% 
were living in Cork, 5% in Galway and 4% in Limerick. All other counties accounted for the remaining 26% of 
responses. 
Figure 3.2 shows the response rate for each county per 10,000 male population aged 17–74 years. The response 
rate per 10,000 male population aged 17–74 years was highest in Dublin (23.1), Limerick (11.0) and Carlow (10.5). 
It was lowest in Longford (3.6), Cavan (3.4) and Monaghan (3.3).
Figure 3.2 Response rate per 10,000 male population of each county in the Republic of Ireland
Data for the male population aged 17–74 years of each county was derived from the Central Statistics Office (CSO) website.12
Respondents were asked ‘How would you describe the place you live?’ and were given several options with an 
estimated population of each option. It should be noted these definitions were automatically given by the EMIS-
2017 survey and are not necessarily accurate in an Irish context. Table 3.2 shows the distribution of respondents 
based on settlement size. Nearly half of respondents lived in a settlement with more than 500,000 people, and 
18% lived in a village or countryside of less than 10,000 inhabitants. 
 
0.1–4.9 5.0–9.9 10.0–14.9 ≥ 15.0
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Table 3.2 Distribution of respondents by settlement size (n=2,070, missing n=13)
Settlement size n %
Very big city or town (≥1 million population) 662 32.0
Big city or town (500,000–999,999 population) 329 15.9
Medium-sized city/town (100,000–499,999 population) 261 12.6
Small city/town (10,000–99,999 population) 454 21.9
Village or countryside (<10,000 population) 364 17.6
3.4 Country of birth, length of residence in Ireland and reasons for 
migration
Seventy-five percent of respondents were born in Ireland and 25% were born abroad. Of those born abroad, 
26% were born in the United Kingdom, 38% were born in other European countries and 19% were born in Latin 
America and the Caribbean (Table 3.3).
Respondents not born in Ireland were born in 65 different countries. The most common countries of birth were 
England (n=80), Brazil (n=62), Northern Ireland (n=34), Poland (n=29) and Germany (n=25). 
Table 3.3 Distribution of respondents born outside Ireland by region of birth as per World Health 
Organization (WHO) regions (amended) (n=514, missing n=3)
Region of birth n %
Europe (excluding UK) 193 37.5
United Kingdom 134 26.1
Latin America and Caribbean 95 18.5
Canada, USA 30 5.8
Western Pacific Region (excl. AU and NZ) 29 5.6
African region 16 3.1
South East Asia 8 1.6
Eastern Mediterranean 7 1.4
Western Pacific Region: AU and NZ 2 0.4
Of the men born abroad, 37% were living in Ireland for more than 10 years, 14% between six and ten years, 33% 
between one and five years and 15% for less than one year. Work and study were the most common reasons 
for men born abroad to come to Ireland (62%). Fewer than one percent of respondents cited seeking asylum or 
coming to Ireland as a refugee as the reason they came to Ireland. 
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3.5 Education, employment and financial coping
3.5.1 Education
The median number of years in education since the age of 16 was six years. Almost all men (97%) had some 
education after the age of 16, and the majority (86%) had more than two years education after 16 years of age. 
Figure 3.3 shows the breakdown of respondents by years in full-time education since the age of 16. 
Figure 3.3 Years spent in full time education since the age of 16 years (n=1,894, missing n=189)
3.5.2 Employment
Overall, 73% of men were in employment, with two-thirds either employed full-time or self-employed. Eighteen 
percent of respondents were students and 5% were unemployed. The remaining men were either retired (2%), on 
long-term sick leave/medically retired (1%) or indicated ‘other’ (1%). 
Table 3.4 shows the association between employment status and age group. The majority of men who were 
employed were aged between 25-39 years (55%), and the majority of students were aged 17-24 years (78%).
Table 3.4 Employment status by age group (n=2,073, missing n=10)
Age group
(years)
Employed n (%)
1,505 (72.6)
Unemployed n (%)
94 (4.5)
Student n (%)
373 (18.0)
Other*n (%)
101 (4.9)
17-24 147 (9.8) 23 (24.5) 290 (77.7) 6 (5.9)
25–39 831 (55.2) 39 (41.5) 73 (19.6) 21 (20.8)
40–54 433 (28.8) 21 (22.3) 8 (2.1) 21 (20.8)
≥55 94 (6.2) 11 (11.7) 2 (0.5) 53 (52.5)
p-value             <0.001
*Other=retired/long-term sick/medically retired/other 
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3.5.3 Financial coping
Men were asked ‘Which of these phrases would you say comes closest to your feelings about your income these 
days?’ and were offered several responses as shown in Table 3.5.
Overall, almost half of men (49%) felt that they were living comfortably or really comfortably and over 17% felt that 
they were struggling or really struggling on their present income. 
Table 3.5 Distribution of respondents by financial coping (n=2,077, missing n=6)
Financial coping n %
Really comfortable 290 14.0
Comfortable 729 35.1
Neither comfortable nor struggling 696 33.5
Struggling 267 12.9
Really struggling 95 4.6
Table 3.6 shows the association between financial coping and employment status. The majority of employed men 
were either living really comfortably or comfortably on their present income, whereas the majority of unemployed 
men (58%) were struggling or really struggling on their current income. Twenty-seven percent of students were 
struggling or really struggling on their current income.
Table 3.6 Financial status by employment status (n=2,071, missing n=12)
Financial status Employed n (%)
n=1,505 
Unemployed n (%)
n=93 
Student n (%)
n=372 
Other*n (%)
n=101
Really comfortable 246 (16.3) 6 (6.4) 26 (7.0) 11 (10.9)
Comfortable 600 (39.9) 8 (8.6) 92 (24.7) 27 (26.7)
Neither comfortable nor struggling 482 (32.0) 25 (26.9) 152 (40.9) 34 (33.7)
Struggling 143 (9.5) 31 (33.3) 78 (21.0) 15 (14.8)
Really struggling 34 (2.3) 23 (24.7) 24 (6.4) 14 (13.9)
p-value             <0.001
*Other=retired/long-term sick/medically retired/other
3.6 Sexual attraction, sexual identity and outness
3.6.1 Sexual attraction
Men were asked ‘Who are you sexually attracted to?’ and were asked to tick as many as apply (see Table 3.7). 
Eighty three percent were exclusively attracted to men, 15% were also attracted to women and 6% were also 
attracted to non-binary people. Figures add up to more than 100% as there is overlap between the latter two 
categories.
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Table 3.7 Sexual attraction of respondents (n=2,081, missing n=2)
n %
Men only 1,723 82.8
Men and women 206 9.9
Men, women and non-binary people 85 4.1
Men and non-binary people 39 1.9
Women only 12 0.6
No one 6 0.3
Women and non-binary people 5 0.2
Non-binary people only 5 0.2
3.6.2 Sexual identity
Men were asked to pick an option to best describe how they think of themselves in terms of sexual identity 
(n=2,083). Most men (81%) identified as gay or homosexual, 13% as bisexual, 1% as straight or heterosexual, 5% 
stated they didn’t use a term and <1% used another term to describe themselves. 
3.6.3 Outness
Outness was defined as the degree to which people were open about their sexual attraction with others. Overall, 
51% of men were out about their attraction to men to all or almost all of the people they knew and 69% were out 
to more than half of the people they knew. Thirty-one percent were out to less than half who knew them, of whom 
15% were only out to a few people, and 6% were not out to anyone.
Table 3.8 shows the association between outness and sexual identity. The majority of MSM (76%) who identified 
as gay were out to more than half of the people who knew them. Nearly three-quarters of men who identified as 
bisexual were out to less than half of the people who knew them and 27% were not out to anyone. 
Table 3.8 Outness by sexual identity (n=2,052, missing n=31)
Outness Gay n (%)
n=1,689
Bisexual n (%)
n=250
Other*n (%)
n=113
All or almost all 981 (58.1) 31 (12.4) 26 (23.0)
More than half 309 (18.3) 36 (14.4) 17 (15.0)
Less than half 169 (10.0) 39 (15.6) 8 (7.1)
Few 188 (11.1) 76 (30.4) 42 (37.2)
None 42 (2.5) 68 (27.2) 20 (17.7)
p-value                  <0.001
*Other=straight/heterosexual, any other term, I don’t usually use a term
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3.7 Partnership status
Respondents were asked if they currently have a ‘steady partner’. Overall, 35% indicated they had a steady 
partner and 59% were single, with the remaining saying it was complicated. 
Of those who had a steady partner, 84% were with one man only, 4% were with more than one man, 10% were 
with one woman only and 2% were in other steady relationships. 
Men with a steady male partner (n=659) were also asked ‘Does your steady male partner have HIV?’ Overall, 2% 
did not know their partner’s HIV status, 89% knew their partner was HIV negative, 8% knew he was HIV positive 
and had an undetectable viral load, and fewer than 1% knew he was HIV positive and that his viral load was 
detectable. 
3.8 Buying and selling sex
All men were asked ‘When was the last time you paid a man to have sex with you? By paid we mean you gave 
him money, gifts or favours in return for sex’ and ‘When was the last time you were paid by a man to have sex 
with him? By paid we mean he gave you money, gifts or favours in return for sex.’ 
Table 3.9 shows the percentage of men who had ever paid for or had been paid for sex with another man. More 
men bought sex than were paid for it in their lifetime (14% versus 12%) and in the last 12 months (6% versus 4%). 
Table 3.9 Distribution of respondents paying/being paid for sex with men 
Time period Paid for sex*
(n=2,017, missing n=66)
Were paid for sex† 
(n=2,020, missing n=63)
n (Cumulative %) n (Cumulative %)
Last 4 weeks 29 (1.4) 29 (1.4)
Last 6 months 58 (4.3) 26 (2.7)
Last 12 months 35 (6.0) 33 (4.4)
Last 5 years 84 (10.2) 55 (7.1)
Ever 80 (14.2) 89 (11.5)
*Paying for sex meant giving money, gifts or favours in return for sex
†Being paid for sex meant being given money, gifts or favours in return for sex
Of those who had paid for sex in the last 12 months (n=122), 39% had done so three or more times, with the 
remainder (61%) paying for sex once or twice. 
Of those who had been paid for sex in the last 12 months (n=88), 48% had done so three or more times, with the 
remainder (52%) being paid for sex once or twice.
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Chapter 4 Reported ill health 
This chapter describes physical and mental ill health reported by MSM and it may be of particular interest to 
healthcare providers and those planning health services for MSM. MSM are disproportionally affected by mental 
health problems. Numerous studies have demonstrated that sexual minorities are at increased risk for anxiety, 
depressive and substance use disorders.13,14  Additionally, poor mental health in MSM has been associated with 
an increased risk of HIV transmission.15 
This chapter includes sections on mental health (anxiety and depression; thoughts of self-harm/better off 
dead; sexual unhappiness; possible alcohol dependency) and HIV and STIs (prevalence of HIV; unsuppressed 
diagnosed HIV; diagnoses of chlamydia, gonorrhoea and syphilis; first diagnosis of anal or genital warts; and past 
or current hepatitis C infection).
4.1 Mental Health 
4.1.1 Indicators of anxiety and depression
The Generalised Anxiety Disorder (GAD-2) screening tool, which consists of the two core criteria for a generalised 
anxiety disorder, was used to assess anxiety in EMIS-2017. All men were asked ‘Over the last 2 weeks, how often 
have you been bothered by the following problems: 
1 Feeling nervous, anxious or on edge
2 Not being able to stop or control worrying?’
Responses to the questions were: not at all (0 points); some days (1 point); more than half the days (2 points); 
nearly every day (3 points).
The two-item Patient Health Questionnaire (PHQ-2), which consists of diagnostic core criteria for depressive 
disorders, was used to assess depression in EMIS-2017. All men were asked ‘Over the last 2 weeks, how often 
were you bothered by the following problems: 
1 Little interest or pleasure in doing things
2 Feeling down, depressed, or hopeless?’ 
Responses to the questions were: not at all (0 points); some days (1 point); more than half the days (2 points); 
nearly every day (3 points).
For GAD-2 and PHQ-2, a total score of three or greater indicates a ‘yellow flag’ and a total score of five or greater 
indicates a ‘red flag’ for anxiety or depression. GAD-2 and PHQ-2 are considered screening tools for anxiety and 
depression, and are not diagnostic tools. Both scales are validated for use in the general population.16
Table 4.1 shows the proportion of men in each category for anxiety and depression. Three-quarters of 
respondents had no indication of anxiety and 79% had no indication of depression. Twenty-five percent had some 
indication of anxiety, with 11% indicating a ‘red flag’ for anxiety. Twenty-one percent of respondents had some 
indication of depression, with 8% indicating a ‘red flag’ for depression. 
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Table 4.1 Prevalence of anxiety and depression among respondents
Anxiety
(n=2,073, missing n=10)
Depression 
(n=2,061, missing n=22)
n (%) n (%)
Normal range (0–2 points) 1,548 (74.7) 1,629 (79.0)
Yellow flag (3–4 points) 306 (14.8) 261 (12.7)
Red flag (≥5 points) 219 (10.6) 171 (8.3)
Both scales have been validated for use in the general population.
4.1.2 Thoughts of self-harm or of being better off dead
All men were asked ‘Over the last 2 weeks, how often have you been bothered by thoughts that you would be 
better off dead, or of hurting yourself in some way?’ This scale has not been validated for use in the general 
population. Table 4.2 shows the proportion of respondents giving each response. 
Overall, 23% of respondents had considered hurting themselves or thought they would be better off dead over the 
past two weeks and 7% had coinsidered it more than half of the days during that time. 
Table 4.2 Prevalence of thoughts of self-harm or of being better off dead in respondents in the last 2 weeks 
(n=2,075, missing n=8)
n %
Not at all 1,603 77.2
Some days 325 15.7
More than half the days 86 4.1
Nearly every day 61 2.9
This scale has not been validated for use in the general population.
4.1.3 Sexual happiness
Men were asked ‘How happy are you with your sex life on a scale of 1 to 10 where 1 is the most unhappy and 10 
is the most happy?’ The average score for sexual happiness was 6.0 (standard deviation 2.3). Figure 4.1 shows 
the profile of scores for this question. 
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Figure 4.1 Profile of sexual happiness of respondents (n=2,071, missing n=12)
This scale has not been validated for use in the general population.
4.1.4 Possible alcohol dependency
The CAGE-4 screening measure was used to assess possible alcohol dependency. The CAGE-4 questionnaire for 
alcohol misuse has been previously validated for use in the general population.17 Men who indicated they drank 
alcohol in the last 12 months [n=1,958 (94% of total sample)] were asked: ‘Thinking about drinking alcohol in the 
past 12 months: 
1 Have you tried to cut down on your drinking 
2 Have people annoyed you by criticising your drinking 
3 Have you felt bad or guilty about your drinking
4 Have you taken a drink first thing in the morning to steady your nerves or get rid of a hangover?’ 
Indicating ‘yes’ to two or more statements indicated possible alcohol dependency and would require further 
evaluation. 
Table 4.3 shows the distribution of responses given by respondents. Thirty one percent of men who consumed 
alcohol in the last 12 months reported possible alcohol dependency which represented 29% of all respondents. 
Table 4.3 Indicators of possible alcohol dependency in respondents who consumed alcohol in the last 12 
months (n=1,952, missing n=6)
n %
Tried to cut down on your drinking 861 44.1
People annoyed you by criticising your drinking 344 17.6
Felt bad or guilty about your drinking 579 29.6
Taken a drink first thing in the morning to steady your nerves or get rid of a hangover 168 8.6
Possible alcohol dependency* 596 30.6
*Indicating yes to two or more of the above statements indicates possible alcohol dependency 
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Information on social determinants of mental health, including social integration, reliable alliance and internalised 
homonegativity of respondents, is covered in section 6.1. The prevalence of homophobic abuse is covered in 
section 7.1.
4.2 HIV and STIs
4.2.1 Prevalence of HIV 
All men were asked if they had ever received an HIV test result and, if yes, what the result was (Table 4.4). Twenty-
three percent had never tested for HIV, 70% had tested negative at their last HIV test and 7% had received a 
positive diagnosis. 
Among the subset of men who had ever tested for HIV (n=1,601), 9% had received a positive HIV diagnosis. 
Table 4.4 HIV testing history (n=2,071, missing n=12)
n %
Never tested 470 22.7
Last test negative 1,459 70.4
Diagnosed positive 142 6.9
Table 4.5 describes the results of HIV tests and the recency of testing. The proportion of men who tested for HIV 
in the previous 12 months (recent testing) was 53%. Among respondents who had tested for HIV in the last year, 
less than 1% were diagnosed positive.
Table 4.5 Recency of last negative test and first positive test (n=2,063, missing n=20)
Testing history Recency of test n % of total
Last test negative
(n=1,458, missing n=1)
≤12 months 1,086 52.6
>12 months 372 18.0
Last test positive 
(n=135, missing n=7)
≤12 months 12 0.6
>12 months 123 6.0
Never tested - 470 22.8
Total - 2,063 100.0
4.2.2 Last viral load in men living with HIV 
Men who had been diagnosed HIV positive (n=142) were asked ‘What was the result of your viral load the last 
time you had your HIV infection monitored?’ Ninety-six percent had an undetectable viral load, 3% did not know 
whether their last viral load was detectable and 1% had a detectable viral load. 
4.2.3 Most recent diagnoses of syphilis, gonorrhoea and chlamydia
Overall, 55% of respondents had tested for an STI (not including HIV) within the previous 12 months, 21% had 
tested more than 12 months ago, and 24% had never tested for an STI. Of those with a history of ever having had 
an STI test, 72% had an STI test in the last 12 months. This topic is further discussed in section 7.8.
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All men were asked ‘When were you last diagnosed with syphilis?’ Identical questions were asked about 
gonorrhoea and chlamydia. Table 4.6 shows the recency of diagnoses of syphilis, gonorrhoea and chlamydia. 
Gonorrhoea was the most commonly diagnosed bacterial STI in the last 12 months (9%), followed by chlamydia 
(6%) and syphilis (3%). Among the subset of respondents who had tested for an STI in the last 12 months 
(n=1,115), the prevalence of gonorrhoea increased to 16%, chlamydia increased to 10% and syphilis increased to 
6%. 
Table 4.6 Recency of STI diagnosis
Time period Syphilis
(n=2,051, missing n=32) 
Gonorrhoea
(n=2,045, missing n=38) 
Chlamydia 
(n=2,038, missing n=45) 
n (Cumulative %) n (Cumulative %) n (Cumulative %)
Last 4 weeks 8 (0.4) 32 (1.6) 11 (0.5)
Last 6 months 23 (1.5) 72 (5.1) 46 (2.8)
Last 12 months 35 (3.2) 81 (9.1) 55 (5.5)
Last 5 years 86 (7.4) 183 (18.0) 155 (13.1)
Ever 79 (11.3) 116 (23.7) 86 (17.3)
Overall, 14% of all men were diagnosed with any bacterial STI (syphilis, chlamydia or gonorrhoea) in the last 
12 months. Among the subset of respondents who had tested for an STI in the last 12 months, the prevalence 
increased to 26%. 
4.2.4 First diagnosis of anal or genital warts
All men (n=2,083) were asked if they had ever been diagnosed with anal or genital warts (n=2,083). Sixteen 
percent (n=327) of men indicated they had ever been diagnosed with anal or genital warts, with 1% of men 
diagnosed in the last 12 months. 
4.2.5 Past and current hepatitis C infection
All men (n=2,083) were asked if they had ever been diagnosed with hepatitis C. One percent (n=24) of 
respondents reported that they were ever diagnosed with hepatitis C, with 0.2% of these first diagnosed in the 
last 12 months. Fewer than 1% of all men were diagnosed with both HIV and hepatitis B or C. 
4.3 Reported ill health in MSM by key characteristics 
This section explores how reported ill health among MSM in Ireland was distributed across several characteristics: 
age, employment status and HIV testing history. The likelihood that differences among individuals in different 
groups were due to chance was established using chi-squared analysis (c2) for continuous variables and 
independent t-test or ANOVA for categorical variables. If the significance value was ≤0.05, there was deemed to 
be a significant difference between the groups. 
Table 4.7 shows reported ill health in MSM by age group. Fifteen percent of respondents aged 17-24 indicated 
a ‘red flag’ for anxiety and 30% had thoughts over the last two weeks that they would be better off dead, or 
of hurting themselves. Less than 1% of 17-24 year olds reported an HIV diagnosis, 8% reported a gonorrhoea 
diagnosis in the last 12 months, 4% reported a chlamydia diagnosis and 1% a syphilis diagnosis. These 
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percentages are lower compared to other age groups (Table 4.7). A higher percentage (17%) of men aged 55 and 
over reported being HIV positive compared to other age groups. 
Twenty percent and 22% of unemployed men had red flags for anxiety and depression, respectively. Forty-one 
percent of unemployed men had thoughts of hurting themselves or of being better off dead in the last two weeks 
and 43% indicated possible alcohol dependency (among men who consumed alcohol within the last 12 months). 
(Table 4.8).
Men with diagnosed HIV reported a higher frequency of gonorrhoea (16%), chlamydia (14%) and syphilis (12%) 
diagnoses in the last 12 months compared to those who never tested for HIV, or those whose last HIV test was 
negative (Table 4.9).
Table 4.7 Reported ill health in MSM by age group
Age groups (n=2,083) 17-24 
(n=469)
25–39 
(n=968)
40-54 
(n=484)
≥55 
(n=162)
All* p value
Reported ill health in MSM
% ‘Red flag’ for anxiety 15.5 10.2 7.9 6.8 10.6 <0.001
% ‘Red flag’ for depression 10.1 8.4 6.7 6.9 8.3 0.281
% Thoughts that you would be better off dead, 
or hurting yourself, last 2 weeks 
29.8 21.2 20.6 17.9 22.7 <0.001
Average sexual happiness self-rating (out of 10) 5.7 6.1 5.8 6.0 6.0 0.004
% Possible alcohol dependency† 29.2 33.0 29.5 22.7 30.6 0.061
% Diagnosed with HIV 0.6 6.9 9.6 16.5 6.9 <0.001
% Gonorrhoea diagnosis last 12 months 7.6 11.3 7.6 4.5 9.0 0.007
% Chlamydia diagnosis last 12 months 4.3 6.4 4.3 7.2 5.5 0.187
% Syphilis diagnosis last 12 months 1.1 3.2 4.2 6.5 3.2 0.004
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
† Among those who indicated they drank alcohol in last 12 months; 17-24 n=448, 25-39 n=917, 40-54 n=441, ≥55 n=141
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Table 4.8 Reported ill health in MSM by employment status
Employment status (n=2,073, missing n=10) Employed 
(n=1,505)
Unemployed 
(n=94)
Student 
(n=373)
Other 
(n=101)
All* p value
Reported ill health in MSM
% ‘Red flag’ for anxiety 8.8 20.2 13.2 16.8 10.5 <0.001
% ‘Red flag’ for depression 6.8 22.3 8.1 15.1 8.2 <0.001
% Thoughts that you would be better off dead, 
or hurting yourself, last 2 weeks 
19.0 40.9 30.4 30.7 22.6 <0.001
Average sexual happiness self-rating (out of 10) 6.1 5.5 5.8 5.7 6.0 0.020
% Possible alcohol dependency† 31.1 42.9 25.6 28.3 30.5 0.014
% Diagnosed with HIV 7.4 9.7 1.3 16.0 6.8 <0.001
% Gonorrhoea diagnosis last 12 months 9.9 3.3 7.6 7.0 9.1 0.088
% Chlamydia diagnosis last 12 months 6.1 2.2 4.0 5.1 5.5 0.212
% Syphilis diagnosis last 12 months 3.6 3.3 1.1 5.0 3.2 0.063
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
† Among those who indicated they drank alcohol in last 12 months; Employed n=1,411, Unemployed n=84, Student n=352, Other n=92 
Table 4.9 Reported ill health in MSM by HIV testing history
HIV testing history (n=2,071, missing n=12) Never 
tested 
(n=470)
Last test 
negative 
(n=1,459)
Diagnosed 
positive 
(n=142)
All* p value
Reported ill health in MSM
% ‘Red flag’ for anxiety 12.7 13.4 9.7 10.6 0.100
% ‘Red flag’ for depression 8.9 12.9 7.7 8.3 0.099
% Thoughts that you would be better off dead, 
or hurting yourself, last 2 weeks 
26.4 21.0 28.9 22.8 0.011
Average sexual happiness self-rating (out of 10) 5.5 5.8 6.1 6.0 <0.001
% Possible alcohol dependency† 26.9 32.0 28.5 30.6 0.119
% Gonorrhoea diagnosis last 12 months 0.6 11.0 16.2 9.0 <0.001
% Chlamydia diagnosis last 12 months 0.9 6.2 14.4 5.5 <0.001
% Syphilis diagnosis last 12 months 0.0 3.3 12.1 3.2 <0.001
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
† Among those who indicated they drank alcohol in last 12 months; Never tested n=427, Last test negative n=1,372, Diagnosed positive 
n=137
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Chapter 5 Risk and precautionary behaviours
This chapter reports on risk and precautionary behaviours reported by MSM, and may be of particular interest 
to those involved in planning, implementing and monitoring interventions to reduce risk behaviours and enable 
precautionary behaviours. There is also a section that reviews behaviours during last sex session in more detail. 
This chapter includes sections relating to: 
•	 HIV	treatment
•	 seeking	and	taking	PEP	and	PrEP
•	 being	vaccinated	against	hepatitis
•	 sex	with	men
•	 sex	with	women
•	 the	use	of	alcohol,	tobacco	and	drugs
•	 injecting	drugs
•	 combining	sex,	drugs	and	alcohol
•	 last	sex	session	with	a	non-steady	partner.
5.1 HIV treatment among men with HIV
Overall, 7% indicated that they had been diagnosed with HIV (see also section 4.2.1). For individuals living with 
HIV, taking effective anti-retroviral treatment (ART) that results in an undetectable viral load prevents HIV being 
transmitted to others. 
5.1.1 HIV antiretroviral treatment
Men living with HIV (n=142) were asked if they had ever taken ART and, if yes (n=134), if they were currently taking 
it. Overall, 94% of men living with HIV had ever taken ART, and of those 99% were currently on ART.
5.1.2 Time between diagnosis and treatment
Men who ever used ART (n=134) were asked ‘How much time was there between your HIV diagnosis and you 
starting treatment?’ 
Twenty-seven percent of men indicated starting treatment for HIV within one month of diagnosis and a further 
30% received treatment within one year of diagnosis. The remainder (43%) started treatment more than a year 
from their diagnosis. 
Table 5.1 shows the relationship between year of diagnosis and average time for starting ART. It should be noted 
that ART was not available in Ireland before 1996. The time between diagnosis and treatment has substantially 
declined over time. The average time for starting ART was two years for men diagnosed between 2006 and 2010 
and was less than three months for men diagnosed in 2016 or 2017. The decrease in time between diagnosis 
and treatment reflects current HSE guidelines which state that all people living with HIV attending HIV services in 
Ireland are offered ART and informed of the benefits of ART in improving their personal health and reducing HIV 
viral load.18
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Table 5.1 Year of diagnosis and average time between diagnosis and starting treatment (n=119, missing 
n=15)
Year of diagnosis n Average time for starting treatment (months)
1991–1995 4 63
1996–2000 8 48
2001–2005 22 52
2006–2010 25 25
2011–2015 42 9
2016–2017 18 3
5.2 Seeking and taking HIV chemoprophylaxis
Men without HIV can reduce their risk of acquiring infection by taking HIV antiviral drugs known as 
chemoprophylaxis (PEP and PrEP). Taken correctly, PEP and PrEP are effective means of protection against HIV 
transmission. 
5.2.1 Seeking and taking Post-Exposure Prophylaxis (PEP) 
Men who were not diagnosed with HIV or who had never tested for HIV (n=1,929) were asked ‘Have you ever tried 
to get PEP (even if you did not take it)?’ Overall, 13% had tried to get PEP. 
Of the men who tried to get PEP (n=252), 72% took at least one course, one in five could not get it and 7% could 
get it but decided not to take it. In the total sample of men (n=1,928), 10% had taken at least one course of PEP, 
while 3% could not get it (Table 5.2).
Table 5.2 Distribution of respondents who had ever/never taken PEP
Ever taken PEP Of those who tried to get PEP*
(n=251, missing n=1)
Total sample*
(n=1,928, missing n=1)
n % n %
No, could not get it 50 19.9 50 2.6
Had the opportunity but didn’t take it 17 6.8 17 0.9
Yes, taken one course of pills 140 55.8 140 7.3
Yes, taken more than one course of pills 42 16.7 42 2.2
I don’t know 2 0.8 2 0.1
Never tried to get PEP - - 1,677 87.0
*excluding men diagnosed HIV positive
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5.2.2 Seeking and taking Pre-Exposure Prophylaxis (PrEP)
Men who were not diagnosed with HIV or who had never tested for HIV (n=1,929) were asked ‘Have you ever tried 
to get PrEP?’ Overall, 10% had tried to get PrEP. 
Of the men who tried to get PrEP (n=198), 55% had never taken PrEP, 31% were taking it daily and 9% were 
taking it on an event-based basis (PrEP is taken at least 24 hours in advance of intercourse in place of taking it 
daily). In the total sample of men (n=1,917), 4% were currently taking PrEP (with 3% taking it daily) and 95% had 
never taken PrEP (Table 5.3).
Table 5.3 Distribution of respondents who had ever/never taken PrEP
Ever taken PrEP Of those who tried to get PrEP*
(n=192, missing n=6)
Total sample*
(n=1,917, missing n=12)
n % n %
No 105 54.7 1,826 95.2
Currently taking it on a daily basis 59 30.7 60 3.1
Used to, but no longer taking it 11 5.7 11 0.6
Currently taking it on event based basis 17 8.9 18 0.9
Don’t know - - 2 0.1
*excluding men diagnosed HIV positive
5.3 Being vaccinated against hepatitis A and B
Forty-eight percent of all men had been fully vaccinated against hepatitis A and 5% had natural immunity to 
hepatitis A. Forty-three percent of respondents did not know if they had been vaccinated against hepatitis A. 
Fifty-three percent of all men had been fully vaccinated against hepatitis B and 4% had natural immunity to 
hepatitis B. Thirty-six percent of men did not know if they had been vaccinated against hepatitis B (Table 5.4). 
Table 5.4 Distribution of respondents who have been vaccinated against hepatitis A/B
Hepatitis vaccination status Hepatitis A 
(n=2,076, missing n=7)
Hepatitis B
(n=2,077, missing n=6)
n % n %
No, I’ve had hepatitis A/B (naturally immune) 99 4.8 86 4.1
No, I have chronic hepatitis B infection - - 6 0.3
Yes, and I have completed the course 997 48.0 1,107 53.3
Yes, but I did not complete the course 97 4.7 88 4.2
Yes, but I did not respond to the vaccinations - - 36 1.7
I don’t know 883 42.6 754 36.3
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5.4 Sex with men
Respondents were told ‘In this survey we use “sex” to mean physical contact to orgasm (or close to orgasm) 
for one or both partners.’ Men were also told ‘In this survey we use the term “intercourse” to mean sex where 
one partner puts their penis into the other partner’s anus or vagina whether or not this occurs to ejaculation. 
Intercourse does not include oral sex or the use of dildos.’ 
Overall, 97% of men had ever had sex with a man and the median age of first sex was 18 years. Ninety-three 
percent of men had sex with a man within the last 12 months. 
Among men who ever had sex with a man (n=2,022), 93% of men had ever had intercourse with a man and the 
median age of first intercourse was 19 years. Eighty-one percent of men had intercourse with a man in the last 12 
months. 
5.4.1 Steady partners in last 12 months
The survey defined the term ‘steady partner’ as ‘boyfriends or husbands that mean you are not “single”, but not to 
partners who are simply sex buddies’. Men who reported having sex in the last 12 months were asked a series of 
questions about a steady partner (n=1,930).
Half of respondents had sex with one or more steady partners in the last 12 months. Of these, 72% reported sex 
with one steady partner, 22% with 2–4 steady partners and 6% with five or more steady partners. 
Among men who had sex with steady partners, 75% had condomless anal intercourse (CAI), 17% had intercourse 
using a condom and 8% did not have any intercourse. 
The majority of men who indicated CAI with a steady partner in the last 12 months reported having one partner 
only (80%), 17% had CAI with 2–4 steady partners and 3% with five or more steady partners. 
5.4.2 Non-steady partners in last 12 months
The survey defined ‘non-steady partners’ to mean ‘men you have had sex with once only, and men you have sex 
with more than once but who you don’t think of as a steady partner (including one-night stands, anonymous and 
casual partners, or regular sex buddies)’. Men who reported having sex in the last 12 months were asked a series 
of questions about non-steady partners (n=1,930).
Proportions of men who had sex with one or more non-steady male partner(s) within the last 12 months are 
summarised in Figure 5.1. Seventy-nine percent reported having sex with non-steady male partners in the last 
12 months. Of these men, 12% reported one non-steady partner, 28% reported 2–4 partners, 21% reported 5–9 
partners and 39% reported 10 or more. Of the men who had sex with at least one non-steady partner in the last 
12 months (n=1,518), 54% reported CAI, 32% had intercourse using a condom and 14% did not have intercourse. 
Among men who had CAI (n=791), 32% had CAI with one non-steady partner, 34% with 2–4 partners, 14% with 
5–9 partners and 19% with 10 or more.
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Figure 5.1 Details of the type of sex men had with one or more non-steady male partner(s) within the last 
12 months (n=1,452, missing n=66)
Men who had intercourse with non-steady partners in the last 12 months (n=1,298) were asked ‘In the last 12 
months, how often were condoms used when you had intercourse with non-steady male partners?’ Thirty-seven 
percent of men reported consistent use of condoms with non-steady partners in the last 12 months, 54% reported 
inconsistent use and 9% never used condoms in the last 12 months with non-steady partners. 
5.4.3 Risk mitigation in condomless anal intercourse with non-steady partners
Seventy-nine percent of men who had sex in the previous 12 months had sex with non-steady partners in the 
last 12 months. Of these, 87% had intercourse with non-steady partners in the last 12 months, and 63% did not 
always use a condom. This is shown by HIV status in Table 5.5.
Table 5.5 Risk mitigation in CAI with non-steady male partners by HIV status 
Sexual behaviour measure Men without diagnosed HIV Men with diagnosed HIV
n/N % n/N %
Sex with non-steady partners in last 12 
months among men who had sex with a man 
in the previous 12 months
1,392/1,767 78.8 116/135 85.9
Intercourse with non-steady male partners in 
last 12 months  among men who had sex with 
a non-steady partner in previous 12 months
1,181/1,376 85.8 108/111 97.3
Inconsistent condom use during intercourse 
with non-steady male partners in last 12 
months among men who had intercourse with 
a non-steady partner in previous 12 months
717/1,179 60.8 90/108 83.3
Serosorting
Men who had indicated inconsistent condom use with non-steady partners in the last 12 months (n=807) were 
asked questions regarding serosorting (the practice of using HIV status as a decision-making point in choosing 
sexual behaviour) and their responses are given in Table 5.6 by HIV status. 
No intercourse
n=198 (14%)
One CAI 
partner
n=254 (32%)
2-4 CAI 
partners
n=272 (34%)
5-9 CAI 
partners
n=114 (14%)
≥ 10 CAI 
partners
n=151 (19%)
CAI
n=791 (54%)
Intercourse with 
condom
n=463 (32%)
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Table 5.6 Distribution of serosorting in respondents who indicated inconsistent condom use by HIV status 
Intercourse with non-steady partners* Men without diagnosed HIV
(n=717)
Men with diagnosed HIV
(n=90)
n % n %
Who you knew at the time was HIV positive 89 12.4 57 63.3
Who you knew at the time was HIV negative 413 57.8 56 62.2
Whose HIV status you did not know or think 
about at the time
487 67.9 71 78.9
*Multiple answers possible
Undetectable viral load and PrEP use
Men who had inconsistent condom use with non-steady partners who they knew at the time were HIV positive 
were asked ‘Did that HIV positive man/those HIV positive men have undetectable viral load?’ Table 5.7 shows the 
responses given by respondents. 
Table 5.7 Knowledge of undetectable viral load of non-steady male partner who was HIV positive among 
men who indicated inconsistent condom use 
Non-steady partner(s) had an undetectable viral load Men without diagnosed HIV (n=89, missing n=0)
n %
Yes, I knew he did/they all did 66 74.2
Yes, I knew some of them did 10 11.2
No, he did not/none of them did 1 1.1
I don’t know 8 9.0
Don’t understand 4 4.5
Men who had inconsistent condom use with non-steady male partners who they knew at the time were HIV 
negative were asked ‘Was that HIV negative man/were those HIV negative men taking PrEP?’ Table 5.8 shows the 
responses given. 
Table 5.8 Knowledge of PrEP use of non-steady male partner who was HIV negative among respondents 
who indicated inconsistent condom use
Non-steady partner was taking PrEP Men without diagnosed HIV
(n=413, missing n=0)
Men with diagnosed HIV
(n=56, missing n=0)
n % n %
Yes, I knew he was/they all were 38 9.2 12 21.4
Yes, I knew some of them were 100 24.2 15 26.8
No, he was not/none of them were 133 32.2 6 10.7
I don’t know 140 33.9 22 39.3
Don’t understand 2 0.5 1 1.8
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5.5 Sex with women
In the total sample, 44% of men (n=900) reported ever having sex with a woman, with 9% reporting they had sex 
with a woman within the past 12 months. Of those who had sex with a woman in the last 12 months (n=195), 9% 
had not had any intercourse with women, 47% had intercourse with one female partner, 27% with 2–4 female 
partners and 17% with five or more partners. 
In men who indicated they had intercourse with at least one woman in the last 12 months (n=178), 31% always 
used condoms and, equally, 31% reported never using condoms. Thirty-eight percent of respondents reported 
inconsistent condom use when having sex with women.
5.6 Use of alcohol, tobacco and drugs
5.6.1 Alcohol, tobacco, poppers and prescription drugs
All men were asked ‘When was the last time you consumed alcohol/tobacco products/poppers (nitrate 
inhalants)?’ They were also asked ‘When was the last time you consumed Viagra, Cialas, Levitra or other 
substances that help to get or keep an erection?’ and ‘When was the last time you consumed sedatives or 
tranquilisers (Valium, Rivotril, Rohypnol, Xanax, Seduxen, Phenazepam)?’ Table 5.9 shows the distribution of 
responses given by respondents.
Table 5.9 Respondent use of alcohol, tobacco, poppers and prescription drugs 
n (Cumulative %) Last 4 weeks Last 12 months Ever
Alcohol
(n=2,079, missing n=4)
1,850 (89.0) 1,958 (94.2) 2,018 (97.1)
Tobacco products
(n=2,078, missing n=5)
783 (37.7) 981 (47.2) 1,356 (65.3)
Poppers
(n=2,078, missing n=5)
585 (28.2) 952 (45.8) 1,332 (64.1)
Erectile dysfunction drugs
(n=2,076, missing n=7)
238 (11.5) 427 (20.6) 619 (29.8)
Sedatives/tranquilizers
(n=2,076, missing n=7)
153 (7.4) 352 (17.0) 573 (27.6)
5.6.2 Other drugs
All men were asked ‘When was the last time you consumed: cannabis (hashish, marijuana); synthetic 
cannabinoids (e.g. Spice, K2, herbal incense); ecstasy (E, XTC, MDMA) in the form of a pill; ecstasy (E, XTC, 
MDMA) in the form of a crystal or powder; amphetamine (speed); crystal meth (Tina, Pervitin); heroin or related 
drugs (poppy straw, kompot, fentanyl); mephedrone (4-MMC, meow, methylone, bubbles); synthetic stimulants 
other than mephedrone (e.g. MXE, bathsalts, 3-MMC, 4-MEC, 4-FA, XTC-light); GHB/GBL (liquid ecstasy); 
ketamine (special K); LSD (acid); cocaine; crack cocaine.’
Table 5.10 shows the frequency with which different drugs were used. Overall, 41% of respondents used drugs 
in the last 12 months and 26% had used drugs in the last four weeks. The most commonly used drugs in the last 
12 months were cannabis (34%), cocaine (20%), ecstasy pills (19%) and ecstasy powder (15%). In the last four 
weeks, cannabis and cocaine were used by 17% and 9% of respondents, respectively. 
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Table 5.10 Respondents use of illicit drugs
n (Cumulative %) Last 4 weeks Last 12 months Ever
Cannabis
(n=2,060, missing n=23)
349 (16.9) 700 (34.0) 1,095 (53.2)
Cocaine
(n=2,057, missing n=26)
185 (9.0) 418 (20.3) 666 (32.4)
Ecstasy pill
(n=2,059, missing n=24)
143 (7.0) 387 (18.8) 681 (33.1)
Ecstasy powder
(n=2,055, missing n=28)
99 (4.8) 309 (15.0) 508 (24.7)
Synthetic cannabinoids
(n=2,053, missing n=30)
16 (0.8) 32 (1.6) 202 (9.8)
Crack cocaine 
(n=2,059, missing n=24)
6 (0.3) 11 (0.5) 48 (2.3)
Heroin or related 
(n=2,060, missing n=23)
7 (0.3) 11 (0.5) 45 (2.2)
Stimulant drugs
Ketamine
(n=2,059, missing n=24)
65 (3.2) 173 (8.4) 335 (16.3)
GHB/GBL
(n=2,058, missing n=25)
66 (3.2) 152 (7.4) 268 (13.0)
Crystal meth
(n=2,056, missing n=27)
31 (1.5) 79 (3.8) 156 (7.6)
Mephedrone
(n=2,057, missing n=26)
10 (0.5) 30 (1.5) 154 (7.5)
Synthetic stimulants other 
than mephedrone
(n=2,059, missing n=24)
9 (0.4) 21 (1.0) 104 (5.1)
Amphetamine
(n=2,057, missing n=26)
32 (1.6) 143 (7.0) 409 (19.9)
LSD
(n=2,057, missing n=26)
20 (1.0) 73 (3.6) 266 (12.9)
Use of any stimulant drug
(n=2,043)
152 (7.4) 331 (16.2) 596 (29.2) 
Any drug use
(n=2,029)
518 (25.5) 838 (41.3) 1,116 (55.0)
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5.7 Injecting drugs
All men were asked ‘Have you ever injected an anabolic steroid (testosterone), or had someone else inject into 
you?’ and ‘Have you ever injected any drug to get high (other than anabolic steroids or prescribed medicines), or 
had someone else inject into you?’ Table 5.11 shows the frequency of drug injecting among respondents. 
Table 5.11 Frequency of drug injecting 
Anabolic steroids
(n=2,074, missing n=9)
Any drug to get high 
(n=2,076, missing n=7)
n % n %
Within last 12 months 25 1.2 17 0.8
More than 12 months ago 18 0.9 26 1.3
Never 2,031 97.9 2,033 97.9
Fewer than 1% of respondents indicated they had injected any drug to get high in the last 12 months and just 
over 1% of respondents had injected anabolic steroids in the last 12 months.
Of men who indicated they injected drugs to get high in the last 12 months (n=17), 59% had done so three times 
or less and three-quarters of men had done it five times or less. Crystal meth was used by 83% of men who 
injected drugs, followed by ketamine (18%). Among men who had injected to get high in the last 12 months 
(n=17), 29% had injected with a used needle or syringe.
5.8 Combining sex, drugs and alcohol
5.8.1 Sex under intoxication
Men who had sex with men in the last 12 months (n=1,930) were asked ‘In the last 12 months, how much of the 
sex you’ve had with men has been under the influence of alcohol or any other drug?’ Over 45% indicated they 
had some sex under the influence of alcohol or any other drug, while 12% said almost all or all sex was under the 
influence (Table 5.12).  
Table 5.12 Recency of sex under intoxication in the last 12 months (alcohol and/or drugs)   
(n=1,929, missing n=1)
Sex under the influence of alcohol or any other drug n %
All of it 79 4.1
Almost all of it 145 7.5
More than half 127 6.6
About half 190 9.8
Less than half 332 17.2
Almost none of it 533 27.6
None of it 523 27.1
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5.8.2 Use of stimulant drugs during sex
Twenty percent of all respondents had ever used stimulant drugs to make sex more intense or last longer and 
14% had done so in the last 12 months. Table 5.13 shows the frequency of use. Stimulant drugs included in this 
definition were: ecstasy/MDMA, cocaine, amphetamine, crystal meth, mephedrone and ketamine. It should be 
noted that ‘chemsex’ was not directly asked about and we are using stimulant drug use during sex as a proxy for 
this. 
In men who indicated they had ever used any illicit recreational drug [n=1,115 (55% of total sample)], 36% had 
ever used stimulant drugs to make sex more intense or last longer and 25% had done so in the last 12 months. 
Table 5.13 Use of stimulant drugs to make sex more intense or last longer 
Recency Whole sample 
(n=2,060, missing n=23)
Men who used any illicit 
recreational drug 
(n=1,155, missing n=0)
Cumulative n Cumulative % Cumulative %
Last 4 weeks 121 5.9 10.5
Last 6 months 211 10.2 18.3
Last 12 months 286 13.9 24.8
Last 5 years 362 17.6 31.3
Ever 415 20.1 35.9
Men who had indicated they had used stimulant drugs during sex in the last 12 months (n=286) were asked ‘When 
was the last time you combined stimulant drugs and sex with more than one man at the same time?’ Table 5.14 
shows the distribution of responses. 
Table 5.14 Recency of stimulant drug use to make sex more intense or last longer with more than one man 
among men who used stimulant drugs during sex in previous 12 months (n=286)
Recency n Cumulative %
Last 4 weeks 64 22.4
Last 6 months 70 46.8
Last 12 months 41 61.2
Last 5 years 29 71.3
Ever 9 74.5
Never 73 -
Overall, 75% of men who had used stimulant drugs during sex in the previous 12 months had experience of doing 
so with more than one partner at once, with 61% doing so in the last 12 months. 
In men who used stimulant drugs during sex with more than one partner in the last 12 months (n=180), 74% had 
done so in private dwellings. 
In men who used stimulant drugs during sex with more than one partner in the last 12 months (n=180), 51% had 
been doing so for less than 3 years, while 14% had engaged in this for more than 10 years.
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5.9 Last sex session with non-steady partners
Men who had any kind of sex with non-steady partners in the last 12 months (n=1,518) were asked to think about 
the most recent occasion they had sex with a non-steady partner (whether or not they had intercourse). This 
section presents information on the last sexual encounter with a non-steady partner in the last 12 months. 
5.9.1 Number of partners involved and if they previously had sex with those non-steady 
partners
Among respondents who reported non-steady partners in the last 12 months, 82% indicated that the last sexual 
encounter was between him and one other non-steady partner, 5% indicated it was between him, his steady 
partner and a non-steady partner, 6% indicated it was between him and two non-steady partners and 7% had sex 
with three or more non-steady partners during their last sexual encounter. 
The majority (62%) of men had not previously had sex with the non-steady partner involved in their latest sexual 
encounter. Of all encounters with non-steady partners, 14% reported the sex was with a partner they had met 
once before and 24% with partners they had met more than once before. Men who had a threesome with two 
non-steady partners were most likely to have had sex with these men previously.
5.9.2 How and where the non-steady partner(s) were met
The most common place men had their first point of contact with their last non-steady partner was on a mobile 
phone (60%), followed by elsewhere on the internet (10%) (Table 5.15). 
Table 5.15 Where respondents met their last non-steady sexual partner (n=1,513, missing n=5)
n %
On my mobile phone 900 59.5
Elsewhere on the internet 145 9.6
Elsewhere 127 8.4
A gay sauna 99 6.5
A gay disco or nightclub 89 5.9
A gay café or gay bar 40 2.6
A gay community centre, gay organisation 37 2.4
A cruising location 32 2.1
A backroom of a bar or gay sex club 28 1.9
A gay sex party in a private home 10 0.7
A porn cinema 6 0.4
The most common place for sex with a non-steady partner was a private home (73%). This was followed by a 
hotel room (10%) and a sauna (7%) (Table 5.16). Multiple partner and group sex more often occurred in saunas, 
sex clubs and backrooms.
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Table 5.16 Locations for sex (n=1,512, missing n=6)
n %
Private home 1,109 73.4
Hotel room 152 10.0
Sauna 101 6.7
Cruising location 70 4.6
Club/backroom 33 2.2
Porn cinema 8 0.5
Other 39 2.6
5.9.3 Sexual acts and condom use 
At their last sexual encounter, mutual masturbation and receptive and insertive oral sex were engaged in by the 
majority of respondents (Table 5.17)
Table 5.17 Sexual acts during the last sexual encounter with a non-steady partner (n=1,493, missing n=25)
n %
Receptive oral sex 1,289 86.3
Insertive oral sex 1,201 80.4
Mutual masturbation 1,197 80.2
Receptive anal intercourse 669 44.8
Insertive anal intercourse 606 40.6
Insertive oral-anal sex 608 40.7
Receptive oral-anal sex 535 35.8
Receptive fisting 97 6.5
Insertive fisting 75 5.0
Use sex toys for penetration 103 6.9
Sharing sex toys for penetration 35 2.3
Other sex acts 117 7.8
Multiple answers possible
Twenty-seven percent of men who reported sex with non-steady partners in the last 12 months reported no anal 
intercourse during their last sexual encounter. One-third reported receptive anal intercourse only, 28% reported 
insertive intercourse only and 12% reported both. 
Thirty-seven percent of men who engaged in anal intercourse with their last non-steady partner did not use a 
condom. Fifty-two percent of men reported consistent condom use and 11% reported inconsistent condom use. 
Consistent condom use was highest when receptive anal intercourse was engaged in and lowest if both insertive 
and receptive anal intercourse were part of the same sex session (Table 5.18).
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Table 5.18 Use of condoms during anal intercourse (n=1,095, missing n=3) 
Receptive anal intercourse 
only
n=489
n (%)
Insertive anal intercourse 
only
n=429
n (%)
Both receptive and 
insertive anal intercourse 
n=177
n (%)
No condom use 164 (33.5) 169 (39.4) 72 (40.7) 
Inconsistent condom use 39 (8.0) 49 (11.4) 31 (17.5) 
Consistent condom use 286 (58.5) 211 (49.2) 74 (41.8) 
5.9.4 Substance use before and during their last sexual encounter with a non-steady 
partner
Of the 1,518 men who answered questions about their last sexual encounter with a non-steady partner, 60% 
(n=904) reported substance use before and/or during sex. 
The most common substances used by respondents before and during sex were alcohol (42%), poppers (29%), 
erectile dysfunction medications (12%), cannabis (8%) and cocaine (5%). Figure 5.2 shows the frequencies of 
reported substance use.
Figure 5.2 Reported substance use by respondents before or during their last sexual encounter with a non-
steady partner
Substance use occurred most frequently in clubs/backrooms of bars and was least likely to occur in cruising 
locations and private homes.
Use of crystal methamphetamine, mephedrone, other synthetic stimulants, GHB/GBL and/or ketamine were most 
common in clubs/backrooms (9%), followed by private homes (8%) and saunas (5%).
Injecting drug use was rare in the overall sample of men who had sex with non-steady partners in the last 12 
months (n=10, 0.6%). 
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5.10 Risk and precautionary behaviours by key characteristics 
This section reports how risk and precautionary behaviours were distributed across several characteristics: age, 
employment status and HIV testing history. The likelihood that differences among individuals in different groups 
were due to chance was established using chi-squared analysis (c2) for continuous variables and independent 
t-test or ANOVA for categorical variables. If the significance value was ≤0.05, there was deemed to be a significant 
difference between the groups.
Just over one-third of respondents aged 17-24 years were vaccinated against hepatitis A and B. Thirty-five 
percent of men aged 55 years and over had CAI with two or more non-steady partners in the last 12 months. 
Sixteen percent of men aged 25–39 years had used stimulant drugs to make sex last longer or more intense in the 
last 12 months and 11% did so with more than one partner (Table 5.19). 
Six percent of unemployed men stated they were taking PrEP on a daily basis compared to 3% in the overall 
sample. Among students, 37% were vaccinated against hepatitis A and 43% were vaccinated against hepatitis B, 
which is lower than among other groups (Table 5.20). 
Men who had a negative HIV test reported a higher percentage of PEP and PrEP taking compared to men who 
had never tested. Men who tested (both positive and negative) reported higher percentages of being vaccinated 
against hepatitis A and B. Fifty-nine percent of men diagnosed with HIV reported CAI with two or more non-steady 
partners in the last 12 months. Twenty-six percent of men diagnosed with HIV reported using stimulant drugs to 
make sex more intense or last longer and the same percentage reported doing so with more than one partner 
(Table 5.21). 
Table 5.19 Risks and precautionary behaviours by age
Age groups n=2,083 17-24
(n=469)
25–39
(n=968)
40-54
(n=484)
≥55
(n=162)
All* p value
Risk and precautionary behaviours
% Ever taken PEP† 4.5 12.9 7.8 8.3 9.4 0.576
% Daily use of PrEP‡ 1.7 3.5 3.7 3.9 3.1 0.256
% Vaccinated against/naturally immune to 
Hepatitis A
34.0 59.3 57.8 53.1 52.8 <0.001
% Vaccinated against/naturally immune to 
Hepatitis B
37.5 64.0 64.8 53.4 57.4 <0.001
% CAI with ≥2 non-steady partners 19.6 29.5 26.0 34.9 26.9 <0.001
% Stimulant drugs used to make sex last 
longer or more intense, in last 12 months
10.9 16.3 14.3 6.9 13.9 0.002
% Used stimulant drugs to make sex last 
longer with >1 partner, in last 12 months
6.0 10.6 9.4 3.7 8.7 0.003
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
† Excluding men diagnosed with HIV; 17-24 n=465, 25-39 n=899, 40-54 n=433, ≥55 n=132
‡ Excluding men diagnosed with HIV; 17-24 n=463, 25-39 n=894, 40-54 n=430, ≥55 n=130 
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Table 5.20 Risks and precautionary behaviours by employment status
Employment status
(n=2,073, missing n=10)
Employed
(n=1,505)
Unemployed
(n=94)
Student
(n=373)
Other
(n=101)
All* p value
Risk and precautionary behaviours
% Ever taken PEP† 10.9 8.3 5.7 3.6 9.5 0.248
% Daily use of PrEP‡ 3.7 6.0 1.1 0.0 3.1 0.009
% Vaccinated against/naturally immune to 
Hepatitis A
57.2 45.2 37.0 50.5 52.7 <0.001
% Vaccinated against/naturally immune to 
Hepatitis B
62.3 47.9 42.5 46.5 57.3 <0.001
% CAI with ≥2 non-steady partners 29.7 27.5 16.1 26.3 26.9 <0.001
% Stimulant drugs used to make sex last 
longer or more intense, in last 12 months
15.7 14.1 8.3 6.1 13.8 <0.001
% Used stimulant drugs to make sex last 
longer with >1 partner, in last 12 months
10.1 12.0 4.0 2.0 8.7 <0.001
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
† Excluding men diagnosed with HIV; Employed n=1,385, Unemployed n=84, Student n=368, Other n=84
‡ Excluding men diagnosed with HIV; Employed n=1,377, Unemployed n=83, Student n=367, Other n=83
Table 5.21 Risk and precautionary behaviours by HIV testing history
HIV testing history
(n=2,071, missing n=12)
Never 
tested
(n=470)
Last test 
negative 
(n=1,459)
Diagnosed 
positive 
(n=142)
All* p value
Risk and precautionary behaviours
% Ever taken PEP 0.2 4.2 - 3.6 <0.001
% Daily use of PrEP 0.2 4.1 - 3.0 <0.001
% Vaccinated against/naturally immune to 
Hepatitis A
20.3 60.7 77.3 52.7 <0.001
% Vaccinated against/naturally immune to 
Hepatitis B
24.4 65.9 77.3 57.2 <0.001
% CAI with ≥2 non-steady partners 10.9 29.1 58.8 26.9 <0.001
% Stimulant drugs used to make sex last 
longer or more intense, in last 12 months
6.2 15.2 26.2 13.9 <0.001
% Used stimulant drugs to make sex last 
longer with >1 partner, in last 12 months
3.0 8.9 25.5 8.7 <0.001
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
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Chapter 6 Needs
This chapter identifies needs of MSM that, if addressed, can lead to better engagement in precautionary sexual 
health behaviours and the avoidance of risk behaviours. This chapter may be of particular interest to statutory and 
NGO health promotion service providers who are planning, implementing and monitoring interventions. 
This chapter contains information relating to needs concerning:
•	 Social	support,	reliable	alliance	and	internalised	homonegativity
•	 Safer	sex	(self-efficacy,	condom	access	and	HIV	and	STI	transmission	knowledge)
•	 Safer	drug	use
•	 Use	of	PEP
•	 Use	of	PrEP
•	 HIV	testing	and	treatment
•	 Viral	hepatitis.
6.1 Social support, reliable alliance and internalised homonegativity
Two key health provisions for MSM are social support and freedom from external and internalised homonegativity. 
In order to reduce the burden on individual respondents, men were randomly assigned either two sub-scales from 
the Social Provisions Scale (four items each for Social Integration and Reliable Alliance), or the Short Internalised 
Homonegativity scale. 
6.1.1 Social Integration and Reliable Alliance
The Social Provisions Scale is a validated scale to measure the availability of social support: emotional support 
or attachment and social integration.19 A random sample of half of respondents (n=1,056) were asked ‘Do you 
disagree or agree with the following eight statements?’
•	 There	is	no	one	who	shares	my	interests	and	concerns.*
•	 There	are	people	who	enjoy	the	same	social	activities	as	I	do.
•	 There	is	no	one	who	likes	to	do	the	things	I	do.*
•	 I	feel	part	of	a	group	of	people	who	share	my	attitudes	and	beliefs.
•	 There	are	people	I	can	count	on	in	an	emergency.
•	 There	is	no	one	I	can	depend	on	for	aid	if	I	really	need	it.*
•	 There	are	people	I	can	depend	on	to	help	me	if	I	really	need	it.
•	 If	something	went	wrong	no	one	would	help	me.*
The first four items measured social integration and the second four measured reliable alliance. Respondents were 
asked to strongly disagree (1 point), disagree (2 points), agree (3 points) or strongly agree (4 points) with the above 
statements. The maximum score available for both social integration and reliable alliance was 16. Questions 
marked with an asterisk had their scales reversed, i.e. the numerical scoring scale ran in the opposite direction.
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Social integration
Social integration is the extent to which people feel they belong in a group. The average [± standard deviation 
(SD)] score on the social integration sub-scale was 12.8 (±2.5) out of 16. The average score (±SD) in the general 
population for social integration was reported previously as 14.0 (±1.9).19 This means that the respondents in this 
survey were slightly less likely on average to feel socially integrated than those in the general population.
Figure 6.1 shows how the scores for the random sample of respondents were distributed. Ideally, individuals 
would be on the right of this scale. 
Figure 6.1 Social integration sub-scale for a random sample of respondents (n=1,040, missing n=16)
Reliable alliance
Reliable alliance is the extent to which people can call on others when they are in need. The average (±SD) reliable 
alliance score was 13.7 (±2.5) out of 16. The average (±SD) in the general population for social integration was 
reported previously as 14.4 (±1.9).19 This means that the respondents in this survey were slightly less likely on 
average to feel that they can call on others when in need than those in the general population.
Figure 6.2 shows how the scores for a random sample of respondents were distributed. Ideally, individuals would 
be on the right of this scale. Almost 40% of men scored maximum points on the scale relating to reliable alliance. 
Figure 6.2 Reliable alliance sub-scale for a random sample of respondents (n=1,021, missing n=35)
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6.1.2 Internalised homonegativity
Negative feelings towards one’s own homosexuality has been shown to be related to higher sexual risk taking and 
lower rates of HIV testing,20 and has been associated with anxiety and depression among MSM.21 The results for 
anxiety and depression for this survey can be found in section 4.1.1. 
The Short Internalised Homonegativity Scale is a validated scale to measure the internalisation of negative 
attitudes and assumptions about homosexual people by homosexual people themselves.22 Men who were not 
asked about the social provisions scale (n=1,027) were asked ‘Do you strongly disagree (1 point) or strongly agree 
(7 points) with the following seven statements?’ 
•	 I	feel	comfortable	in	gay	bars.
•	 I	feel	comfortable	being	seen	in	public	with	an	obviously	gay	person.
•	 I	feel	comfortable	discussing	homosexuality	in	a	public	situation.
•	 I	feel	comfortable	being	a	homosexual	man.
•	 Homosexuality	is	morally	acceptable	to	me.
•	 Even	if	I	could	change	my	sexual	orientation,	I	wouldn’t.
•	 Social	situations	with	gay	men	make	me	feel	uncomfortable.
The above seven items form a single scale measuring ‘internalised homonegativity’. This score was computed by: 
rescaling the items from 1–7 to 0–6 and reversing the scores for the first six items.
The seven responses sum to a score of between 0–42 which was divided by 7 to give a total score between zero 
and six, with zero being the ‘best’ score.
The average (±SD) score on the internalised homonegativity scale was 1.3 (±1.3) out of 6. This was similar to the 
overall European score from EMIS-2017 of 1.5.
Figure 6.3 shows how the scores were distributed. Ideally, individuals would be on the left of this scale. Thirty-one 
percent of respondents scored zero, representing the ‘best’ possible score. 
Figure 6.3 Internalised homonegativity sub-scale for a random sample of respondents   
(n=947, missing n=80)
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6.2 Safer sex
6.2.1 Self-efficacy
All men were asked if they agreed or disagreed with the following two statements: ‘The sex I have is always as 
safe as I want it to be’ and ‘I find it easy to say “no” to sex I don’t want’.
Table 6.1 shows the responses to each statement. Sixteen percent did not agree the sex they have is always as 
safe as they want it to be and 12% did not agree that they find it easy to say ‘no’ to sex they do not want. 
Table 6.1 Distribution of responses to self-efficacy statements
The sex I have is always as safe as I want it
to be (n=2,079, missing n=4)
I find it easy to say no to unwanted sex 
(n=2,077, missing n=6)
n % n %
Strongly agree 778 37.4 846 40.7
Agree 790 38.0 803 38.7
Neither/not sure 179 8.6 181 8.7
Disagree 234 11.3 182 8.8
Strongly disagree 98 4.7 65 3.1
6.2.2 Lack of condom during intercourse
Men were asked about the last time they had CAI solely because they did not have a condom. The responses are 
shown in Table 6.2. In the last 12 months, 27% of men indicated they had CAI solely because they did not have a 
condom. 
Table 6.2 Recency of CAI because they did not have a condom (n=2,076, missing n=7)
n % Cumulative %
Last 4 weeks 203 9.8 9.8
Last 6 months 195 9.4 19.2
Last 12 months 152 7.3 26.5
Last 5 years 230 11.1 37.6
More than 5 years ago 160 7.7 45.3
Never 1,136 54.7 -
6.2.3 HIV and STI transmission knowledge
Six statements were used to assess knowledge about HIV and STI transmission by asking respondents whether 
or not they knew the statements were true. Respondents were given the following options: I knew this already; 
I wasn’t sure about this; I didn’t know this already; I don’t understand this; and I do not believe this. Those who 
answered ‘I knew this already’ were considered to have pre-existing knowledge and the rest were defined as the 
proportion with knowledge gaps. Table 6.3 shows the knowledge gaps for HIV and STI transmission. 
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Overall, basic knowledge about HIV/STI transmission was generally high. One percent of respondents did not 
already know any of the six HIV/STI transmission facts and 84% knew at least five of the six facts. The average 
number of facts known about HIV/STI transmission was 5 out of 6.
Table 6.3 Knowledge gaps for HIV and STI transmission
Already knew 
n (%)
Didn’t already 
know n (%)
HIV cannot be passed during kissing, including deep kissing, because saliva does 
not transmit HIV
(n=2,074, missing n=9)
1,745 (84.1) 329 (15.8)
You can pick up HIV through your penis while being ‘active’ in anal or vaginal sex 
without a condom, even if you don’t ejaculate
(n=2,076, missing n=7)
1,747 (84.2) 329 (15.8)
You can pick up HIV through your rectum or vagina while being ‘passive’ during sex
(n=2,062, missing n=21)
1,963 (95.2) 99 (4.8)
Most STIs can be passed on more easily than HIV (n=2,077, missing n=6) 1,573 (75.7) 504 (24.3)
Because they sometimes have no symptoms, people can have STIs without 
knowing it
(n=2,077, missing n=6)
1,925 (92.7) 152 (7.3)
The correct use of condoms throughout intercourse reduces the likelihood of picking 
up and passing on STIs (n=2,079, missing n=4)
2,031 (97.7) 48 (2.3)
6.3 Safer drug use
Men who indicated they used any of the following drugs: poppers, sedatives, cannabis, synthetic cannabinoids, 
ecstasy pills, ecstasy powder, amphetamine, crystal methamphetamine, heroin, mephedrone, synthetic stimulants 
other than mephedrone, GHB/GBL, ketamine, LSD, cocaine or crack cocaine in the last 12 months (n=1,361) were 
asked ‘Do you disagree or agree with the following statement: I worry about my recreational drug use’. Table 6.4 
shows the responses given by respondents.
Twenty-two percent of respondents who indicated drug use said they don’t take drugs in response to this 
question. This may be because these men do not see themselves as recreational drug users. 
Table 6.4 Distribution of respondents who reported taking drugs who worry about their drug use (n=1,333, 
missing n=28)
n % 
Strongly agree 31 2.3
Agree 77 5.8
Neither/not sure 135 10.1
Disagree 306 23.0
Strongly disagree 485 36.4
Don’t take drugs 299 22.4
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6.4 Use of PEP
6.4.1 Awareness of PEP
Eighty-three percent of all men had heard of PEP and 13% were unaware of PEP, with the remainder not sure if 
they had heard of PEP. 
6.4.2 Knowledge of PEP
Three statements assessed respondents’ knowledge about PEP using the same knowledge response set as 
section 6.2.3. Table 6.5 shows the knowledge gaps for PEP. The average number of facts known about PEP was 2 
out of 3. 
Table 6.5 Knowledge gaps for PEP
Already knew 
n (%)
Didn’t already 
know n (%)
PEP attempts to stop HIV infection taking place after a person is exposed to the 
virus (n=2,077, missing n=6)
1,542 (74.2) 535 (25.8)
PEP is a one-month course of anti-HIV drugs (n=2,078, missing n=5) 954 (45.9) 1,124 (54.1)
PEP should be started as soon as possible after exposure, preferably within hours 
(n=2,073, missing n=10)
1,389 (67.0) 684 (33.0)
6.4.3 Confidence in accessing PEP
Men not diagnosed with HIV (n=1,929) were asked ‘How confident are you that you could get PEP if you thought 
you needed it?’ 
Overall, 22% of men were not at all confident they could access PEP if they required it. Conversely, 45% of men 
were either quite confident or very confident they could get PEP if they needed it.
6.5 Use of PrEP
6.5.1 Awareness of PrEP
Eighty-six percent of men had heard of PrEP and 11% were unaware of PrEP, with the remainder not sure they 
had heard of PrEP. 
6.5.2 PrEP knowledge
Three statements assessed respondents’ knowledge about PrEP using the same knowledge response set as 
section 6.2.3. Table 6.6 shows the knowledge gaps for PrEP.
Twenty-nine percent of men did not know the purpose of PrEP and 40% did not know it can be taken as a single 
daily pill in advance of sex. The average number of facts known about PrEP was 2 out of 3.
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Table 6.6 Knowledge gaps for PrEP
Already knew 
n (%)
Didn’t know
n (%)
PrEP involves someone who does not have HIV taking pills before as well as after 
sex to prevent them getting HIV (n=2,073, missing n=10)
1,480 (71.4) 593 (28.6)
PrEP can be taken as a single daily pill if someone does not know in advance when 
they will have sex (n=2,073, missing n=10)
1,242 (59.9) 831 (40.1)
If someone knows in advance when they will have sex, PrEP needs to be taken as a 
double dose approx. 24 hours before sex and then at both 24 and 48 hours after the 
double dose (n=2,071, missing n=12)
402 (19.4) 1,669 (80.6)
6.5.3 Intention to use PrEP
Men not diagnosed with HIV (n=1,929) were asked ‘If PrEP was available and affordable to you, how likely would 
you be to use it?’ 
Nearly half of respondents (49%) were likely to use PrEP if it was available and affordable, 24% were unlikely to 
use it and 27% were unsure. 
6.6 HIV testing and treatment
6.6.1 Knowledge of HIV status 
All men were asked ‘What do you think your current HIV status is (whether or not you’ve ever tested for HIV)?’ 
Thirty-seven percent of men were unsure of their HIV status (33% probably negative; 4% not sure; 0.3% probably 
positive), with the remainder sure they were either HIV negative (56%) or HIV positive (7%).
6.6.2 HIV test and treat knowledge
Seven statements assessed respondents’ knowledge about HIV testing and treatment using the same knowledge 
response set as section 6.2.3. Table 6.7 shows the knowledge gaps for HIV testing and treatment. 
Overall, a high proportion of respondents knew the HIV testing and treatment facts presented to them. Fifty nine 
percent of respondents knew that a person with HIV who is on effective treatment (called ‘undetectable viral load’) 
cannot pass their virus to someone else during sex. The average number of facts known about HIV testing and 
treatment was 6 out of 7.
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Table 6.7 Knowledge gaps for HIV testing and treatment 
Already knew 
n (%)
Didn’t already 
know n (%)
AIDS is caused by a virus called HIV (n=2,081, missing n=2) 2,028 (97.4) 53 (2.6)
You cannot be confident about whether someone has HIV or not from their 
appearance (n=2,081, missing n=2)
2,011 (96.6) 70 (3.4)
There is a medical test that can show whether or not you have HIV (n=2,080, missing 
n=3)
2,051 (98.6) 29 (1.4)
If someone becomes infected with HIV it may take several weeks before it can be 
detected in a test (n=2,081, missing n=2)
1,779 (85.5) 302 (14.5) 
There is currently no cure for HIV infection (n=2,081, missing n=2) 1,933 (92.9) 148 (7.1) 
HIV infection can be controlled with medicines so that its impact on health is much 
less  (n=2,073, missing n=10 )
2,000 (96.5) 73 (3.5)
A person with HIV who is on effective treatment (called ‘undetectable viral load’) 
cannot pass their virus to someone else during sex (n=2,081, missing n=2)
1,231 (59.1) 850 (40.9)
6.6.3 Knowing where to get an HIV test
As stated in section 4.2.1, 77% of men had ever tested for HIV and 23% (n=470) had never tested for HIV. Of men 
who had never tested, 27% did not know where to get an HIV test and 18% were not sure. 
6.7 Viral hepatitis
6.7.1 Where to access hepatitis vaccinations
Men who were not vaccinated or not naturally immune to hepatitis A (n=980, 47% of total sample) or hepatitis 
B (n=878, 42% of total sample) were asked ‘Do you know where you could get vaccinated against hepatitis A 
or hepatitis B?’ Forty percent of men did not know where to get hepatitis A vaccination and 17% were not sure. 
Thirty eight percent of men did not know where to get hepatitis B vaccination and 17% were not sure.
6.7.2 Hepatitis A and B knowledge
Five statements assessed respondents’ knowledge about hepatitis A and B using the same knowledge response 
set as section 6.2.3. Table 6.8 shows the knowledge gaps for hepatitis A and B. 
Twenty three percent of men did not know that vaccines exist for hepatitis A and B and 37% of men did not know 
that doctors recommend that MSM are vaccinated against hepatitis A and B. The average number of facts known 
about hepatitis was 3 out of 5. 
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Table 6.8 Knowledge gaps for hepatitis A and B
Already knew 
n (%)
Didn’t already 
know n (%)
‘Hepatitis’ is an inflammation of the liver (n=2,079, missing n=4) 1,245 (59.9) 834 (40.1)
Most hepatitis is caused by viruses (n=2,077, missing n=6) 1,379 (66.4) 698 (33.6)
There are several types of hepatitis viruses, named after the letters of the alphabet 
(n=2,079, missing n=4)
1,784 (85.8) 295 (14.2)
Vaccines exist for both hepatitis A and hepatitis B (n=2,079, missing n=4) 1,608 (77.3) 471 (22.7)
Doctors recommend men who have sex with men are vaccinated against both 
hepatitis A and hepatitis B viruses (n=2,079, missing n=4)
1,301 (62.6) 778 (37.4)
6.8 Needs by key characteristics
This section reports how needs of MSM were distributed across several characteristics: age, employment status 
and HIV testing history. The likelihood that differences among individuals in different groups were due to chance 
was established using chi-squared analysis (c2) for continuous variables and independent t-test or ANOVA for 
categorical variables. If the significance value was ≤0.05, there was deemed to be a significant difference between 
the groups.
Table 6.9 shows the breakdown of needs by age group. Men in the youngest age group (17-24 years) and in the 
oldest age group (≥55 years) reported higher frequencies of not being able to say no to unwanted sex compared 
to other age groups. Similarly, 20% of both 17-24 year olds and ≥55s were unaware of PrEP. Forty-eight percent 
of men aged 55 and over knew that a person on effective HIV treatment cannot pass HIV on during sex. This is 
compared to 59% of the overall sample. Fifty-six percent of 17-24 year olds who have never tested for HIV did not 
know where to test for HIV (Table 6.9). 
Unemployed men reported the lowest average score for social integration and reliable alliance compared to other 
employment categories. Furthermore, a quarter of unemployed men who indicated they had taken drugs were 
worried about their drug use. This is compared to the overall average of 11% (Table 6.10). 
Men who had never tested for HIV reported a higher internalised homonegativity score than men who had tested 
for HIV. Men who had never tested for HIV reported lower knowledge compared to those who had ever tested; 
32% were unaware of PrEP; only 39% knew that a person on effective HIV treatment cannot pass on HIV during 
sex; and half did not know where to get hepatitis A or B vaccination. Men who had been diagnosed with HIV 
reported with higher frequency that the sex they have is not always as safe as they want it to be (26% compared 
to 16% in the overall sample) (Table 6.11). 
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Table 6.9 Needs by age group
Age groups
(n=2,083)
17-24
(n=469)
25–39
(n=968)
40-54
(n=484)
≥55
(n=162)
All* p value
Needs
Average social integration† (out of 16) 13.0 12.9 12.6 12.6 12.8 0.388
Average reliable alliance† (out of 16) 13.7 13.9 13.4 13.4 13.7 0.049
Average internalised homonegativity † (out of 6) 1.4 1.2 1.3 1.6 1.3 0.062
% Sex not as safe as I want it to be 14.3 16.6 14.1 22.2 16.0 0.161
% Did not find it easy to say ‘no’ to unwanted 
sex
14.7 11.9 8.3 14.2 11.9 <0.001
% CAI because lacked condom, last 12 
months
29.8 27.4 22.3 24.2 26.5 0.050
Mean number of 7 HIV/STI transmission facts 
already known
6.0 6.5 6.4 6.1 6.3 <0.001
% Concerned about drug use‡ 6.8 12.5 10.3 7.3 10.4 0.096
% Unaware of PrEP 19.9 8.5 15.8 20.1 13.7 <0.001
Average number of 3 PEP facts already known 1.5 2.1 1.9 1.6 1.9 <0.001
Average number of 3 PrEP facts already known 1.3 1.7 1.4 1.2 1.5 <0.001
Average number of 6 HIV test and treat facts 
already known
4.9 5.5 5.3 5.0 5.3 <0.001
% Knew a person with undetectable viral load 
cannot pass on HIV
54.1 65.2 55.9 47.5 59.2 <0.001
% Did not know where to test for HIV◆ 56.0 39.4 34.2 27.3 45.4 <0.001
Average number of 5 hepatitis facts already 
known
3.0 3.6 3.8 3.6 3.5 <0.001
% Did not know where to get hepatitis A 
vaccination if not immune/vaccinated∞ 50.0 38.6 30.9 28.0 39.7 <0.001
% Did not know where to get hepatitis B 
vaccination if not immune/vaccinated∞ 47.9 36.1 29.8 28.0 38.1 <0.001
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
†Subset of respondents were asked either the lack of social integration and reliable alliance questions OR the internalised homonegativity 
questions
Social Integration – 17-24 years n=227, 25–39 years n=493, 40–54 years n=242, ≥55 years n=78
Reliable Alliance – 17-24 years n=221, 25–39 years n=483, 40–54 years n=240, ≥55 years n=77
Internalised homonegativity – 17-24 years n=213, 25–39 years n=435, 40–54 years n=223, ≥55 years n=76
‡ Of those who indicated drug use in last 12 months – 17-24 years n=278, 25–39 years n=654, 40–54 years n=302, ≥55 n=99
◆ Of those never tested for HIV – 17-24 years n=218, 25–39 years n=142, 40–54 years n=76, ≥55 years n=33
∞ Of those who are not naturally immune/not already vaccinated –
Hepatitis A – 17-24 years n=306, 25–39 years n=389, 40–54 years n=201, ≥55 years n=75
Hepatitis B – 17-24 years n=290, 25–39 years n=344, 40–54 years n=168, ≥55 years n=75
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Table 6.10 Needs by employment status
Employment status
(n=2,073, missing n=10)
Employed
(n=1,505)
Unemployed
(n=94)
Student
(n=373)
Other
(n=101)
All* p value
Needs
Average social integration† (out of 16) 12.8 12.1 13.2 12.4 12.8 0.033
Average reliable alliance† (out of 16) 13.8 12.6 13.8 13.6 13.7 0.018
Average internalised homonegativity † (out 
of 6)
1.3 1.4 1.4 1.5 1.3 0.284
% Sex not as safe as I want it to be 16.0 17.2 15.0 18.8 16.0 0.934
% Did not find it easy to say ‘no’ to 
unwanted sex
10.8 16.0 15.3 11.9 11.9 <0.001
% CAI because lacked condoms, last 12 
months
27.2 28.0 26.6 15.8 26.6 0.095
Average number of 7 HIV/STI transmission 
facts already known
6.4 6.0 6.1 6.3 6.3 <0.001
% Concerned about drug use‡ 10.1 25.5 8.6 9.4 10.5 0.007
% Unaware of PrEP 11.7 17.4 17.7 23.0 13.6 <0.001
Average number of 3 PEP facts already 
known
2.0 1.7 1.6 1.6 1.9 <0.001
Average number of 3 PrEP facts already 
known
1.6 1.4 1.4 1.2 1.5 0.003
Average number of 6 HIV test and treat 
facts already known
5.4 5.2 5.1 5.0 5.3 <0.001
% Knew a person with undetectable viral 
load cannot pass on HIV
59.8 60.6 59.0 46.5 59.1 0.071
% Did not know where to test for HIV◆ 41.4 41.9 52.1 39.1 45.2 0.164
Average number of 5 hepatitis facts 
already known
3.6 3.1 3.2 3.5 3.5 <0.001
% Did not know where to get hepatitis A 
vaccination if not immune/vaccinated∞ 37.7 45.1 45.9 32.7 39.8 0.002
% Did not know where to get hepatitis B 
vaccination if not immune/vaccinated∞ 34.3 44.9 47.2 35.9 38.1 0.020
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
†Subset of respondents were asked either the lack of social integration and reliable alliance questions OR the internalised homonegativity 
questions
Social Integration – employed n=764, unemployed n=47, student n=176, other n=49
Reliable Alliance – employed n=748, unemployed n=47, student n=172, other n=51
Internalised homonegativity – employed n=682, unemployed n=44, student n=174, other n=44
‡ Of those who indicated drug use in last 12 months – employed n=988, unemployed n=57, student n=223, other n=58
◆ Of those never tested for HIV – employed n=244, unemployed n=31, student n=167, other n=23
∞ Of those who are not naturally immune/not already vaccinated –
Hepatitis A – employed n=637, unemployed n=51, student n=233, other n=49
Hepatitis B – employed n=560, unemployed n=49, student n=214, other n=53
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Table 6.11 Needs by HIV testing history
HIV testing history
(n=2,071, missing n=12)
Never 
tested
(n=470)
Last test 
negative
(n=1,459)
Diagnosed 
positive 
(n=142)
All* p value
Needs
Average social integration† (out of 16) 12.8 12.9 12.6 12.8 0.644
Average reliable alliance† (out of 16) 13.6 13.8 13.4 13.7 0.360
Average internalised homonegativity† (out of 
6)
1.7 1.2 1.2 1.3 <0.001
% Sex not as safe as I want it to be 11.4 16.6 26.1 16.1 <0.001
% Did not find it easy to say ‘no’ to unwanted 
sex
11.1 11.7 16.2 11.9 0.222
% CAI because lacked condoms, last 12 
months
25.3 26.9 25.3 26.4 0.757
Average number of 7 HIV/STI transmission 
facts already known
5.8 6.4 6.6 6.3 <0.001
% Concerned about drug use‡ 8.9 12.9 10.5 10.4 0.596
% Unaware of PrEP 31.8 9.0 2.1 13.7 <0.001
Average number of 3 PEP facts already 
known
1.1 2.0 2.6 1.9 <0.001
Average number of 3 PrEP facts already 
known
1.0 1.6 2.1 1.5 <0.001
Average number of 6 HIV test and treat facts 
already known
4.6 5.4 5.9 5.3 <0.001
% Knew a person with undetectable viral load 
cannot pass on HIV
39.2 62.1 93.0 59.0 <0.001
Average number of 5 hepatitis facts already 
known
2.6 4.2 3.7 3.5 <0.001
% Did not know where to get hepatitis A 
vaccination if not immune/vaccinated◆
51.1 34.2 9.7 39.8 <0.001
% Did not know where to get hepatitis B 
vaccination if not immune/vaccinated◆
50.0 31.8 3.2 38.1 <0.001
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
† Subset of respondents were asked either the lack of social integration and reliable alliance questions OR the internalised homonegativity 
questions
Social Integration – Never tested n=238, last test negative n=721, diagnosed positive n=76 
Reliable Alliance – Never tested n=235, last test negative n=708, diagnosed positive n=72 
Internalised homonegativity – Never tested n=201, last test negative n=678, diagnosed positive n=62 
‡ Of those who indicated drug use in last 12 months – Never tested n=230, last test negative n=974, diagnosed positive n=120
◆ Of those who are not naturally immune/not already vaccinated –
Hepatitis A – Never tested n=370, last test negative n=568, diagnosed positive n=31
Hepatitis B – Never tested n=354, last test negative n=491, diagnosed positive n=31
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Chapter 7 Interventions
To intervene is to participate in an activity so as to alter a course of events, usually to make something less or 
more likely to occur. This chapter is aimed at those who plan, deliver and evaluate interventions and outlines the 
types of interventions that can influence needs such as homophobic abuse or access to services. 
EMIS-2017 asked about the following interventions:
•	 Homophobic	abuse:	intimidation,	insults,	and	violence
•	 Access	to	condoms
•	 Substance	use	services
•	 PrEP	services
•	 HIV/STI	education	services
•	 HIV	testing	and	HIV	cascade	of	care
•	 Viral	hepatitis	vaccination
•	 STI	testing	services
•	 Partner	notification	for	syphilis	and	gonorrhoea	diagnoses.
7.1 Homophobic abuse: intimidation, insults, and violence
Information on mental health indicators is covered in section 4.1. Social integration, reliable alliance and 
internalised homonegativity of respondents are covered in section 6.1. 
All men were asked about the last time they were stared at, had verbal insults directed at them or were physically 
assaulted because someone knew, or presumed, they were attracted to men.
Table 7.1 shows the recency of homophobic abuse as indicated by respondents. One in five men had ever been 
physically assaulted because someone had known, or presumed, they were attracted to men, with 3% having 
been being assaulted in the last 12 months. Seventy percent of men had been verbally insulted because someone 
had known, or presumed, they were attracted to men, and 28% of men had experience of this in the last 12 
months.
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Table 7.1 Recency of homophobic abuse
Stared at/intimidated
(n=2,079, missing n=4)
Verbally insulted
(n=2,078, missing n=5)
Physically assaulted 
(n=2,077, missing n=6)
n Cumulative % n Cumulative % n Cumulative %
Last 4 weeks 307 14.8 172 8.3 11 0.5
Last 6 months 220 25.3 201 17.9 25 1.7
Last 12 months 223 36.1 199 27.5 30 3.2
Last 5 years 362 53.5 434 48.4 108 8.4
Ever* 313 68.5 442 69.7 285 22.1
*Ever in this circumstance is cumulative percentage of any homophobic abuse ranging from last 24 hours to more than 5 years ago
7.2 Access to condoms
Condom distribution is a key intervention for increasing access to condoms, and condom packs often carry health 
promotion information on and in their packaging. 
All men were asked ‘Where have you got condoms from in the last 12 months?’ and were asked to tick as many 
as apply to them from the range of sources. Table 7.2 shows the responses given by respondents.
Fifteen percent of all men did not access condoms in the last 12 months. Of men who got condoms in the last 12 
months (n=1,756), the single most common source for condoms was buying them from a physical shop (51%). 
The remainder relied on a range of sources, 14% had gotten them free from clinics and 12% had gotten them free 
from gay clubs or bars. 
Among those who accessed condoms in the last 12 months, 56% of respondents had accessed free condoms 
from a clinic or gay bars/clubs or saunas or gay/HIV community organisations. 
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Table 7.2 Source of condoms in the last 12 months among those who got condoms
Condom access in last 12 
months
(n=1,756, missing n=0)
Single most common source of 
condoms 
(n=1,752, missing n=4)
n % n %
Bought at a shop 1,110 63.2 888 50.7
Free from clinics 574 32.7 245 14.0
Free from gay bars or clubs 573 32.6 208 11.9
From friends or sex partners 352 20.0 78 4.4
Free from sauna 314 17.9 92 5.2
Free from gay or HIV community organisations 302 17.2 78 4.4
Bought online 141 8.0 90 5.1
Bought from a vending machine 116 6.6 31 1.8
Other answer 63 3.6 42 2.4
Accessed free condoms* 987 56.2
*Free condoms from clinics or gay bars/clubs or saunas or gay/HIV community organisations
7.3 Substance use services
All men were asked three questions on consulting substance services: ‘Have you ever consulted a health 
professional for your alcohol use concerns?’, ‘Have you ever consulted a health professional for your drug use 
concerns?’ and ‘Have you ever attended a self-help group, harm reduction programme or counsellor about your 
drug use?’ Two percent of all respondents consulted a health professional about their alcohol use and 3% about 
their drug use in the last 12 months. Half of the men who consulted a health professional about their drug use also 
attended a self-help group, harm reduction programme or counsellor.
7.4 PrEP services
7.4.1 Speaking to MSM about PrEP
Among men without diagnosed HIV (n=1,929), 18% indicated someone in the Irish health service had spoken to 
them about PrEP. Those men were asked ‘Which health service has spoken to you about PrEP?’ The responses 
are shown in Table 7.3.
Table 7.3 Health services where respondents were spoken to about PrEP (n=356, missing n=1)
Which health service has spoken to you about PrEP? n % 
Hospital or clinic as an out-patient 210 59.1
Community service or drop-in 121 34.1
General practitioner/family doctor 29 8.2
Doctor in private practice 27 7.6
Other answer 17 4.8
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7.4.2 Consulting a healthcare professional before using PrEP
Among men who had ever taken PrEP (n=89, section 5.2.2), 71% of men had spoken to a healthcare professional 
before taking PrEP.
7.4.3 Prescribing PrEP
Among men who had ever taken PrEP (n=89), 30% had received a medical prescription for PrEP. The majority 
(74%) of those men were prescribed it in a hospital/clinic as an outpatient. 
7.4.4 Source of PrEP 
Men who had ever taken PrEP (n=89) were asked ‘Where have you got your PrEP pills from?’ Table 7.4 shows the 
breakdown of responses given for all men who had taken PrEP and men who had taken PrEP with and without a 
prescription. 
Table 7.4 Source of PrEP pills in men who had ever taken PrEP
Source of PrEP pills Men who had ever taken 
PrEP (n=89)
n (%)
With no prescription (n=62)
n (%)
With prescription
(n=27)
n (%)
From an online pharmacy 49 (55.1) 42 (67.7) 7 (25.9)
At a hospital or clinic 20 (22.5) 11 (17.7) 9 (33.3)
In a research study 9 (10.1) 4 (6.4) 5 (18.5)
From a pharmacy 7 (7.9) 0 (0.0) 7 (25.9)
Other answer 4 (4.5) 4 (6.4) 0 (0.0)
General practitioner/family 
doctor
2 (2.2) 2 (3.2) 0 (0.0)
A doctor in private practice 2 (2.2) 1 (1.6) 1 (3.7)
I used PEP pills as PrEP 3 (3.4) 1 (1.6) 2 (7.4)
I used someone else’s ART 
pills as PrEP
2 (2.2) 2 (3.2) 0 (0.0)
At a community service or 
drop-in
1 (1.1) 0 (0.0) 1 (3.7)
7.5 HIV/STI education services
All men were asked ‘When was the last time you saw or heard any information about HIV or STIs specifically for 
men who have sex with men?’ The majority of men (91%) had seen MSM-specific information about HIV or STIs 
in the last 12 months and 64% had done so in the last 4 weeks. 
7.6 HIV testing and monitoring services
7.6.1 HIV test offers by health services
As stated in section 4.2.1, 23% of men (n=470) had never tested for HIV. Men who had never tested for HIV were 
asked ‘Have you ever been offered an HIV test by a health service?’ 
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Nine percent of those men had ever been offered an HIV test by someone in the Irish health service and 88% 
indicated they had not (remainder indicated they did not know). 
7.6.2 Settings for HIV testing and diagnoses
Table 7.5 shows the settings where respondents were initially diagnosed with HIV. The majority (39%) were initially 
diagnosed at a hospital/clinic as an outpatient, followed by at a community health service or drop-in service 
(19%). 
Table 7.5 Settings for HIV diagnosis (n=142, missing n=0)
Settings for HIV diagnosis n % 
At a hospital or clinic as an out-patient 55 38.7
At a community health service or drop-in 27 19.0
General practitioner/family doctor 26 18.3
At a hospital as an in-patient 17 12.0
A doctor in private practice 13 9.1
At a blood bank, while donating blood 1 0.7
Self-testing kit 1 0.7
Bar/pub, club or sauna 1 0.7
Elsewhere 1 0.7
Men whose last test was negative were asked ‘Where did you go for your last HIV test?’ Table 7.6 shows the 
responses given by respondents. The majority (41%) got their last HIV test in a hospital/clinic as an outpatient, 
followed by at a community health service or drop-in clinic (23%).
Table 7.6 Settings for last HIV test where it was negative
Settings for HIV testing (n=1,456, missing n=3) n % 
At a hospital or clinic as an out-patient 602 41.3
At a community health service or drop-in 337 23.1
General practitioner/family doctor 224 15.4
A doctor in private practice 151 10.4
Bar/pub, club or sauna 47 3.2
At a hospital as an in-patient 22 1.5
Self-sampling kit 21 1.4
At a blood bank, while donating blood 14 1.0
Elsewhere 15 1.0
Self-testing kit 13 0.9
Mobile testing unit 10 0.7
63
CHAPTER 7 INTERVENT IONS
7.6.3 Acceptability of post-HIV diagnosis support and information
Men with diagnosed HIV were asked ‘When you were diagnosed HIV positive, how satisfied were you with the 
support and information you received?’ 
The distributions of responses are shown in Table 7.7. Ninety-four percent of men diagnosed with HIV stated they 
got some form of support or information after their diagnosis. Twenty-two percent of men were dissatisfied with 
the support or information received.
Table 7.7 Acceptability of post-HIV diagnosis support
Diagnosed HIV (n=142, missing n=0)
n %
Did not receive any support or information 4 2.8
Very satisfied 46 32.4
Satisfied 57 40.1
Dissatisfied 16 11.3
Very dissatisfied 15 10.6
I don’t remember/I did not think about it 4 2.8
7.6.4 Satisfaction with post HIV test support by the setting in which HIV diagnosis 
occurred
The setting for HIV diagnosis was compared to the level of post-HIV test support received by respondents. 
Table 7.8 shows the settings for HIV positive diagnosis compared to satisfaction with information received. 
Overall, respondents who were diagnosed with HIV in a community health service/drop-in clinic were most 
satisfied with the support and information they received compared to other settings. Respondents who were 
diagnosed in a hospital/clinic as an outpatient and those who were diagnosed in a GP facility were least satisfied 
with the level of support they received post-HIV diagnosis. 
Table 7.8 Settings for HIV positive diagnosis by satisfaction with information received
Settings for HIV diagnosis
(n=142, missing n=0)
n (%)
Satisfied with 
information received
Dissatisfied with 
information received
Did not receive any 
information
Don’t remember
At a hospital or clinic as an 
out-patient (n=55)
37 (67.3) 14 (25.5) 2 (3.6) 2 (3.6)
At a community health 
service or drop-in (n=27)
23 (85.2) 3 (11.1) 0 (0.0) 1 (3.7)
General practitioner/family 
doctor (n=26)
15 (57.7) 9 (34.6) 1 (3.9) 1 (3.9)
At a hospital as an in-patient
(n=17)
14 (82.4) 3 (17.6) 0 (0.0) 0 (0.0)
A doctor in private practice
(n=13)
10 (76.9) 2 (15.4) 1 (7.7) 0 (0.0)
Others (n=4) 4 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
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7.6.5 HIV continuum of care
As mentioned previously (Section 4.2.1), 142 respondents were diagnosed HIV positive. Of these men, 100% had 
their HIV ever medically monitored, and 99% had their HIV medically monitored in the last 6 months. Of those 
men, 94% were currently taking ART and of those men, 97% indicated they had an undetectable viral load at their 
last check-up. 
The overall proportion of MSM with diagnosed HIV with an undetectable viral load was 91%. 
Figure 7.1 Continuum of care for men diagnosed with HIV
B is a subset of A, C is a subset of B and D is a subset of C.
7.7 Offers of hepatitis vaccination
All men were asked ‘Have you ever been offered any hepatitis vaccination by a health service?’ Overall, 65% of 
men had been offered vaccination against hepatitis by someone in the Irish health service, 31% indicated that 
they had not and the remaining indicated that they did not know.
7.8 STI testing services
All men were asked ‘When did you last have a test for STIs other than HIV?’ Table 7.9 shows the recency of STI 
testing in respondents. Fifty-five percent of respondents had an STI test in the last 12 months. Eighty-four percent 
of men who had an STI test in the last 12 months were asymptomatic on that occasion.
Table 7.9 Recency of STI testing in respondents who had previously had an STI test (n=2,035, missing n=48)
n % Cumulative %
Last 4 weeks 288 14.1 14.1
Last 6 months 554 27.2 41.4
Last 12 months 273 13.4 54.8
Last 5 years 301 14.8 69.6
Ever 124 6.1 75.7
Never 495 24.3
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7.8.1 Awareness of clients’ sexuality among STI test providers
The majority (89%) of respondents who had an STI test in the last 12 months indicated that their health care 
provider definitely knew they had sex with men.
7.8.2 Comprehensive STI screening
Men who had an STI test in the last 12 months (n=1,115) were asked about what elements of an STI screening 
they had experienced in the last 12 months. Table 7.10 shows the responses given by respondents.
Table 7.10 Elements of STI screening experienced by respondents in the last 12 months
Elements of STI screening experienced Yes
n
Yes
%
Blood test (n=1,108, missing n=7) 1,068 96.4
Urine sample (n=1,105, missing n=10) 1,017 92.0
Urethral swab (n=1,080, missing n=35) 418 38.7
Penis examination (n=1,089, missing n=26) 592 54.4
Anal swab (n=1,102, missing n=13) 833 75.6
Anus examination (n=1,091, missing n=24) 465 42.6
Full STI screen* (Blood test, anal swab + urine sample) (n=1,086, missing n=29) 796 73.3
*A full STI screen recommended for MSM in Ireland is: blood test, anal swab, pharyngeal swab, urine sample. However, it was not asked if a 
pharyngeal swab was taken at their last STI screen. 
7.9 Partner notification for syphilis and gonorrhoea diagnoses
Men who had been diagnosed with either syphilis (n=61, 3% of total sample) or gonorrhoea (n=179, 9% of total 
sample) in the last 12 months were asked if they (or their healthcare provider) had informed their recent sexual 
partners of their diagnosis. Eighteen percent and 21% told none of their sexual partners they were diagnosed 
with syphilis or gonorrhoea, respectively. Thirty-six percent and 40% of men notified all of their sexual partners 
and 46% and 39% notified some of their sexual partners when they were diagnosed with syphilis or gonorrhoea, 
respectively. 
7.10 Interventions by key characteristics 
This section reports how interventions for MSM were distributed across several characteristics: age, employment 
status and HIV testing history. The likelihood that differences among individuals in different groups were due to 
chance was established using chi-squared analysis (c2) for continuous variables and independent t-test or ANOVA 
for categorical variables. If the significance value was ≤0.05, there was deemed to be a significant difference 
between the groups.
Forty four percent of men aged 17-24 years reported being verbally insulted because someone assumed or knew 
they were attracted to men. Nearly half of 17-24 year olds reported never testing for HIV and over half reported not 
testing for an STI (other than HIV) in the last 12 months. Across all age groups there was a high percentage of men 
who saw or heard information about HIV or STIs for MSM in the last 12 months. In those who had tested for an 
STI in the last 12 months, the majority got a full STI screen (blood test, anal swab and urine sample) across all age 
groups (Table 7.11) 
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Forty two percent of men who were students reported being verbally insulted because someone assumed or 
knew they were attracted to men. Seventy-eight percent of unemployed men saw or heard information about 
HIV or STIs for MSM in the last 12 months; this is compared to 91% in the overall sample. Forty-five percent of 
students had never tested for HIV and 53% had not tested for an STI in the last 12 months (Table 7.12). 
Men who never tested for HIV reported consistently low numbers of engagement in interventions. Three percent 
of men who never tested for HIV had been spoken to about PrEP at a health service, compared to 23% of men 
whose last HIV test was negative and 19% who were HIV positive. Twenty-three percent of men who had never 
tested for HIV were offered a hepatitis vaccination compared to 75% of those whose last test was negative and 
89% of men who were HIV positive. Nine percent of men who never tested for HIV had an STI test (other than HIV) 
in the last 12 months and, of those, only 32% reported a full STI screen (Table 7.13).
Table 7.11 Interventions by age group
Age groups
(n=2,083)
17-24
(n=469)
25–39
(n=968)
40-54
(n=484)
≥55
(n=162)
All* p value
Interventions
% Verbal insults, because attracted to men in 
the last 12 months
44.1 28.2 15.3 12.3 27.5 <0.001
% Accessed free condoms, last 12 months† 57.5 57.5 53.9 51.1 56.2 0.374
% Spoke to someone about drug use 
concerns
2.4 2.5 2.5 5.0 2.6 0.293
% Spoken to about PrEP at health service 15.2 22.0 15.5 14.8 18.4 0.001
% Saw or heard information about HIV or STIs 
for MSM last 12 months
85.4 93.0 93.0 93.9 91.4 <0.001
% Never tested for HIV 46.6 14.7 16.1 20.9 22.7 <0.001
% Used community-based HIV testing at last 
test
13.7 25.4 17.7 16.8 20.3 <0.001
% Ever been offered any hepatitis vaccination 46.3 73.6 66.3 57.5 64.6 <0.001
% Tested for STI last 12 months 46.3 60.3 52.4 53.3 54.8 <0.001
% Full STI screen last 12 months‡ 71.8 74.5 73.8 66.7 73.3 0.498
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
†Among those who got condoms in the last 12 months – 17-24 years n=393, 25–39 years n=842, 40–54 years n=382, ≥55 years n=139
‡Among those who had an STI test in the last 12 months – 17-24 years n=213, 25–39 years n=561, 40–54 years n=237, ≥55 years  n=75
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Table 7.12 Interventions by employment status
Employment status
(n=2,073, missing n=10)
Employed
(n=1,505)
Unemployed
(n=94)
Student
(n=373)
Other
(n=101)
All* p value
Interventions
% Verbal insults, because attracted to 
men in the last 12 months
25.1 28.7 41.5 11.9 27.6 <0.001
% Accessed free condoms, last 12 
months†
55.2 56.3 59.6 57.1 56.1 0.572
% Spoke to someone about drug use 
concerns
2.1 9.6 2.2 5.9 2.6 <0.001
% Spoken to about PrEP at health service 19.7 15.0 16.4 9.9 18.5 0.079
% Saw or heard information about HIV or 
STIs for MSM last 12 months
93.4 78.4 86.6 92.2 91.4 <0.001
% Never tested for HIV 16.4 33.3 44.8 23.0 22.6 <0.001
% Used community-based HIV testing at 
last test
23.2 8.2 12.2 20.9 20.4 <0.001
% Ever been offered any hepatitis 
vaccination 
69.7 51.1 50.3 53.5 64.6 <0.001
% Tested for STI last 12 months 57.6 49.4 47.1 47.9 54.9 0.001
% Full STI screen last 12 months ‡ 74.2 72.7 72.2 59.1 73.2 0.172
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
†Among those who got condoms in the last 12 months – employed n=1,277, unemployed n=71, student n=319, other n=84
‡Among those who had an STI test in the last 12 months – employed n=826, unemployed n=44, student n=169, other n=44
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Table 7.13 Interventions by HIV testing history
HIV testing history
(n=2,071, missing n=12)
Never 
tested
(n=470)
Last test 
negative
(n=1,459)
Diagnosed 
positive 
(n=142)
All* p value
Interventions
% Verbal insults, because attracted to men in 
the last 12 months
29.3 27.7 19.7 27.5 0.077
% Accessed free condoms, last 12 months† 32.7 61.4 68.1 56.1 <0.001
% Spoke to someone about drug use 
concerns
1.9 2.7 4.2 2.6 0.313
% Spoken to about PrEP at health service 2.6 23.2 19.1 18.2 <0.001
% Saw or heard information about HIV or 
STIs for MSM last 12 months
78.9 95.0 95.2 91.3 <0.001
% Used community-based HIV testing at last 
HIV test
- 27.0 16.7 20.4 <0.001
% Ever been offered any hepatitis vaccination 23.1 75.4 88.6 64.4 <0.001
% Tested for STI last 12 months 8.8 66.2 85.7 54.7 <0.001
% Full STI screen last 12 months‡ 32.4 74.8 72.2 73.1 <0.001
* ‘All’ are the results of cross-tab analysis between two variables, and as a result the figure may differ slightly than what was reported in the 
previous sections due to variance in numbers
†Among those who got condoms in the last 12 months – never tested n=349, last test negative n=1,279, diagnosed HIV positive n=116
‡Among those who got an STI test in the last 12 months – never tested n=37, last test negative n=926, diagnosed HIV positive n=115
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Chapter 8 Discussion
The overall aim of EMIS-2017 was to generate data useful for planning HIV and STI prevention and care 
programmes and to monitor progress in this area. This report offers an up-to-date picture of the sexual health and 
wellbeing of MSM and the needs and behaviour of MSM in Ireland. It provides valuable information for a number 
of audiences, including the MSM community, policy makers and those planning and delivering sexual health and 
wellbeing interventions for MSM.
Overall, EMIS-2017 recruited 137,000 men from 50 countries, of whom 2,083 lived in Ireland. With a crude 
response rate of 13.5 per 10,000 male population aged 15–65 years, Ireland was in the top five countries for the 
highest response in EMIS-2017.23 Men in EMIS-2017 Ireland had a median age of 33 years (range 17–74 years). 
Not all men identified as gay; 13% identified as bisexual. Half of respondents were out to all or almost all people 
who knew them. A quarter of men were not born in Ireland, of those 40% had lived here for more than ten years, 
with work and study the most common reasons for migration into Ireland. Of those not born in Ireland, nearly two-
thirds were from other European countries, and almost one-fifth were from Latin America. 
Mental health
Using validated screening tools, 11% had scores indicating a red flag for anxiety and 8% had scores indicating a 
red flag for depression. In this context, a red flag indicates a need for further assessment and diagnosis of anxiety 
or depression. A higher proportion of red flags for anxiety were indicated in 17-24 year olds (16%) compared to 
other age groups. Twenty-three percent of men had considered hurting themselves or thought they would be 
better off dead in the past two weeks; this again was higher in 17-24 year olds (30%) compared to other age 
groups. 17-24 year olds also reported the highest prevalence of being verbally insulted because of assumed 
attraction to men (44%) compared to other age groups, and compared to the overall prevalence (28%). A similar 
trend was observed in the overall European report, where 37% of younger men reported being verbally insulted 
compared to the overall prevalence of 21% 23. 
Sexual assertiveness
Sexual assertiveness is the ability to negotiate safer sex. Sixteen percent stated that the sex they had wasn’t 
always as safe as they would like it to be and 12% of men stated they did not find it easy to say ‘no’ to unwanted 
sex. Similar findings have been observed in previous surveys.7, 8, 9 Since 2000, the Gay Health Network along with 
the Gay Men’s Health Service has addressed the issue of sexual consent with provision of personal development 
courses. These courses are provided by Outhouse for MSM aged ≥25 years and by BeLonG To Youth Service for 
MSM aged ≤24 years. Information on what to do if there was no consent during sex is also available on man2man.
ie (http://man2man.ie/what-to-do-if/what-to-do-if-there-was-no-consent/). Additionally, work has been ongoing 
in universities to identify sexual assault and the negotiation of sexual consent. A report published by the National 
University of Ireland, Galway, has proven that educational campaigns are possible in this area.24 While this work 
is extremely valuable, the majority of the campaigns are heteronormative, and additional work is required to tailor 
campaigns to the MSM population, with involvement of the MSM community and NGOs. 
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Alcohol and other drug use
The prevalence of alcohol consumption in the last 12 months among men in EMIS-2017 Ireland (94%) slightly 
exceeded the European prevalence (91%).23 The prevalence of possible alcohol dependency among men, which 
was determined using a validated screening tool, was considerably higher in Ireland (29%) compared to the 
overall European prevalence (18%). It has previously been reported that alcohol consumption is higher among 
MSM when compared to the general population.25 Ireland has one of the highest rates of per capita consumption 
of alcohol in the world,26 and it is concerning that MSM in Ireland appear to have a higher prevalence of alcohol 
consumption and possible alcohol dependency compared to MSM in other European countries. 
The prevalence of illicit drug use (excluding poppers) in the previous 12 months was 41% among all respondents 
in EMIS-2017 Ireland. The most commonly used drugs over the last 12 months were cannabis (34%), cocaine 
(20%) and ecstasy pills (19%). The same drugs were most commonly reported in the overall European report, 
however, the use of these drugs was substantially lower compared to Ireland; cannabis (24%), cocaine (10%) and 
ecstasy pills (8%).23 The use of nearly all drugs in EMIS-2017 Ireland was higher when compared to data from 
MISI-2015.11
Chemsex
The use of stimulant drugs to make sex last longer or more intense can be defined as ‘chemsex’. The prevalence 
of stimulant drug use among MSM during or before sex (ever) was higher in Ireland (20%) compared to the overall 
European prevalence (15%).23 Additionally, 72% of men who used stimulant drugs to make sex more intense or 
last longer had done so with more than one partner and this was also higher than the overall European proportion 
(66%). A study carried out in an Irish setting had similar findings to EMIS-2017 Ireland on the use of stimulant 
drugs during or before sex.27
Chemsex has been associated with increased HIV and STI transmission27, 28 and it has also been observed that 
men who engage in chemsex were more likely to do things during chemsex that they wouldn’t do when sober.27 
The National Drug Strategy for Ireland ‘Reducing Harm, Supporting Recovery – a health-led response to drug 
and alcohol use in Ireland 2017–2025’ included recommendations in relation to chemsex. The recommendations 
included the establishment of a chemsex working group that would examine the evidence in relation to early 
harm reduction responses and it also recommended that consideration needed to be given for specialist referral 
pathways for lesbian, gay, bisexual, transgender and intersex (LGBTI) people who use drugs and alcohol who may 
not otherwise engage in traditional addiction services.29 A chemsex working group has been established and the 
aim of the group is to address the topic of chemsex as well as the harms associated with its related substance 
misuse by developing harm reduction and awareness campaigns. Information campaigns on the use of GHB/
GBL (G) during chemsex have been developed and resources from this campaign include: a ‘G Card’, a G poster, 
information fact sheets/booklets and a G Harm Reduction video. Additionally, chemsex workshops, facilitated by 
GMHS and HIV Ireland, have provided information on chemsex to medical and psychiatric departments who may 
be in contact with men who engage in chemsex. 
HIV testing
Twenty-three percent of men had never tested for HIV. While this is lower than previously reported in earlier 
surveys,9, 10 continued and improved access to HIV testing is needed. Men aged 17-24 had the highest frequency 
of having never tested for HIV (47%) compared to other age groups. The lower prevalence of HIV and STIs in 
17-24 year olds observed in EMIS-2017 Ireland may reflect the fact that this age group are not testing. A pilot 
study on monitoring of voluntary community-based HIV testing (VCBT) was recently conducted in Ireland. Overall 
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4,846 community-based HIV tests were carried out in 2018 and 29% of those were first time testers for HIV.30 
This shows the merit of community testing services in providing an important and accessible option where 
individuals can have an HIV test, particularly for those who have never tested for HIV. In June 2019, Dublin, Cork, 
Galway and Limerick joined the HIV Fast-Track Cities initiative. Funding of €450,000 has been provided by the 
Irish government for this initiative. It is envisaged that this funding will support community HIV awareness and 
community testing in Dublin, Cork, Limerick and Galway, as well as a national stigma reduction campaign 31. It is 
hoped that this initiative will increase HIV testing among people most at risk for HIV infection. 
Treatment as prevention for men living with HIV 
Seven percent of all men reported that they were living with HIV, and this varied by age, with a prevalence of 17% 
among men 55 years and over. Almost all men with HIV were engaged in care (i.e. had their CD4 count and viral 
load count monitored every 3–6 months) and 94% of those were on ART. Of men on ART, 97% reported being 
virally supressed. In 2013, UNAIDS set a target with an aim of ending HIV transmission. The target (commonly 
known as 90-90-90) is that by 2020, 1) 90% of all people living with HIV will know their HIV status, 2) 90% of all 
people with diagnosed HIV infection will receive ART, 3) 90% of all people receiving ART will have sustained viral 
suppression and 4) there will be 0% tolerance of HIV stigma.32 Data from EMIS-2017 Ireland suggest that MSM 
in Ireland achieved the second and third targets. The latest report on the HIV continuum of care in Ireland, where 
the number of people living in Ireland with HIV was estimated using modelling, demonstrated that Ireland has 
achieved the third target and is close to achieving the first and second.33 It is hoped that the Fast-Tracks Cities 
initiative will help Ireland to achieve all three 90-90-90 targets and reduce stigma for those diagnosed with HIV. 
It was observed that the length of time from diagnosis to treatment for HIV in Ireland has reduced substantially 
from an average of two years in 2006–2010 to three months in 2016–2017. In 2015, the Department of Health 
(DoH) launched their first national sexual health strategy to improve sexual health and wellbeing and reduce 
negative sexual health outcomes.18 Part of this strategy included the use of ART for HIV prevention by treating 
those with established infection, known as Treatment as Prevention (TasP). In 2017, the DoH recommended that 
all people diagnosed with HIV in Ireland should be offered ART as soon as possible and informed of the benefits 
of ART in eliminating HIV transmission and improving their personal health.18 The data from EMIS-2017 Ireland 
supports the findings from the first national audit of the HIV care continuum whereby people (including MSM) 
living with HIV are receiving ART promptly and achieving undetectable viral loads. 
Almost 60% of men knew that a person with HIV, who is on effective treatment and has an undetectable viral load, 
cannot pass their virus to someone else during sex. This is slightly higher than the European proportion of 57%.23 
A landmark study, recently published in the Lancet Medical Journal, found that men whose HIV infection was 
fully suppressed by ART had effectively zero risk of transmitting HIV to their partner.34 This was the first study to 
provide conclusive evidence that the risk of HIV transmission in gay couples through condomless sex, when HIV 
viral load is supressed, is effectively zero. It supports the message of U=U (undetectable=untransmittable). 
PrEP
Despite there being no formal PrEP programme in place, there was a slightly higher prevalence of current use 
of PrEP (daily or event-based) in Ireland (4%) compared to the overall European average (3%).23 A recent Health 
Technology Assessment (HTA) by the Health Information and Quality Authority (HIQA) found that a formal PrEP 
programme in Ireland would be safe, effective and cost saving.35 Work is ongoing for a PrEP programme to be 
rolled out towards the latter part of 2019. 
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Overall, there was a high awareness of PrEP at 86% and this was substantially higher than the European figure 
(63%). While overall awareness was high, it was lower in some groups such as men who had never tested for HIV 
(68%). Never testing for HIV appeared to be a proxy for a lack of engagement in services, as those who had never 
tested for HIV also had the lowest frequency of STI testing, hepatitis vaccination uptake, and PEP and PrEP use. 
It is noteworthy that in the first year of its PrEP programme, Scotland saw that one-fifth of its participants had no 
prior attendance at HIV/STI services.36 It has been hypothesised that the freely accessible and highly advertised 
PrEP programme attracted people at risk of HIV who would not normally access sexual health services. As part of 
the Scottish PrEP programme roll-out, an education and awareness campaign was carried out. Resources for that 
campaign included a dedicated website about PrEP in Scotland and information booklets about PrEP for service 
providers and patients. 
Condomless anal intercourse and STIs
Men in EMIS-2017 Ireland had a higher prevalence of CAI (54%) with non-steady partners compared to that 
reported in MISI-2015 (42%).11 The high prevalence of CAI with non-steady partners was coupled with a higher 
prevalence of gonorrhoea (9%) and chlamydia (6%) diagnoses in the last 12 months compared to the European 
average (5% and 5%, respectively), but not syphilis, which was 3% in Ireland and 4% in the European report. This 
trend in increasing STI diagnoses is reflected in the surveillance data as discussed in Chapter 1. Further analyses 
of the MISI-2015 data observed that a number of factors were independently associated with an STI diagnosis 
(syphilis, chlamydia or gonorrhoea) including having two or more non-steady CAI partners in the previous 
12 months.37 This reiterates the importance of condom use for STI prevention. It is noted that the higher STI 
prevalence among HIV positive men may indicate that condoms are being primarily used as an HIV transmission 
prevention measure. 
Twenty-seven percent of men in EMIS-2017 Ireland indicated they had CAI solely because they did not have 
a condom at that time; this is comparable to the overall European figure of 26%.23 Interestingly, just 16% of 
MISI-2015 respondents reported having CAI solely because they did not have a condom. It should be noted 
that since the EMIS-2017 survey was carried out there has been a large increase in the availability of condoms 
in response to the increase of HIV and other STIs among MSM. The National Condom Distribution Service 
(NCDS), established in October 2015, distributes free condoms and lubricant sachets to HSE services and other 
organisations working directly with individuals and groups who may be at increased risk of negative sexual health 
outcomes. In 2018, 409,319 condoms were distributed to 16 statutory services, 26 student unions/student health 
services and 22 NGOs/community organisations.38 The most commonly used services for obtaining condoms 
were GMHS and GHN Outreach, GMHS clinic and SHCPP Outreach, two of which are services exclusively for 
MSM. 
Hepatitis A and B vaccinations
Ireland has a higher uptake of hepatitis A (48%) and B (53%) vaccinations compared to the overall European 
average (40% and 45% for hepatitis A and B, respectively).23 This is in part due to the administration of hepatitis 
vaccinations as part of routine STI testing in HIV/STI clinics. However, while there was a relatively high uptake 
of vaccination among EMIS-2017 Ireland respondents, there was also a high percentage of respondents who 
did not know their immune status. In addition there was a relatively low level of general knowledge of hepatitis 
A and B among respondents in EMIS-2017 Ireland. Thirty-seven percent of all respondents did not know that 
doctors recommend MSM should be vaccinated against hepatitis A and B and this increased to 57% among non-
vaccinated men. 
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Chapter 9 Conclusions and opportunities for action and 
research
There was a high response rate to EMIS-2017 among MSM in Ireland. This has allowed us to produce meaningful 
results that are essential to plan responses and interventions for MSM in Ireland. 
Overall, the findings suggest that there has been some positive progress in the sexual health of MSM in recent 
years. The majority of men who were living with HIV were engaged in care, were virally supressed, had high rates 
of STI screening and hepatitis A and B vaccination uptake. Among all MSM, there has been an increase in HIV 
and STI testing compared to previous surveys and this is in some part due to the positive interventions carried out 
by stakeholders and the MSM community in response to findings from previous surveys. Some of these positive 
interventions in relation to HIV testing can also be attributed to the increased availability of community testing. 
However, there is still room for improvement, mainly in the areas of risk behaviour relating to HIV and STI 
transmission. What is also of concern is the number of respondents indicating red flags for anxiety and 
depression, particularly younger MSM. Additional work is also required to better understand chemsex and how 
best to mitigate the negative outcomes associated with it. 
It is now the task of stakeholders to act on these findings to improve the health and wellbeing of MSM in Ireland. It 
is envisaged that the findings contained in this report will be an important resource for stakeholders. 
Opportunities for action and research 
The following areas for action and research have been identified by the EMIS-2017 Ireland steering group as 
topics that are essential for improving the sexual health and wellbeing of MSM in Ireland. 
Health promotion and improvement
•	 There	is	a	need	to	do	a	feasibility	study	into	the	possibility	of	integrating	the	SAOR	tool	(a	screening	and	brief	
intervention for problem alcohol and substance use) into routine STI screening.
•	 Further	work	is	needed	to	develop	specific	health	and	wellbeing/health	improvement	messaging	for	MSM.
•	 There	is	a	need	to	tailor	existing	training	and	information	within	the	area	of	consent	to	the	MSM	population,	
particularly among younger MSM. It should also be considered how information on sexual consent can be 
introduced through the education system. 
•	 An	education	and	awareness	campaign	on	PrEP,	particularly	trying	to	reach	those	who	have	not	previously	
engaged with services, should be done as part of the roll-out of the PrEP programme as recommended by 
HIQA and the Gay Health Network. Within this campaign, men who are on PrEP and who are having sex with 
non-steady partners/non-exclusive partners, should be encouraged to use condoms to reduce the risk of 
acquiring an STI.
•	 There	is	a	need	for	a	campaign	focused	on	the	U=U	message	to	encourage	MSM	with	HIV	to	take	up	
treatment and those not diagnosed to get tested. 
•	 Health	promotion	messaging	should	be	developed	to	encourage	a	culture	among	MSM	to	carry	condoms	for	
the purpose of reducing the risk of STI transmission as well as HIV. 
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•	 Campaigns	concerning	the	awareness	of	hepatitis	among	MSM	are	currently	ongoing	and	these	should	be	
continued and strengthened, particularly in light of ongoing outbreaks of hepatitis A among MSM in Europe.39
•	 Outreach	to	MSM	who	have	migrated	to	Ireland	needs	to	be	further	supported.	
Clinical practice
•	 More	MSM,	particularly	younger	and	older	cohorts,	need	to	be	encouraged	to	get	an	HIV	test	and	to	have	
regular STI screening. In order to achieve this, current STI services should be expanded, and new models of 
STI and HIV testing explored.
•	 An	adult	immunisation	register	and	electronic	vaccination	passport	should	be	developed	for	both	caregivers	
and individuals to know what vaccinations have been received by an individual. This is particularly important 
for MSM for whom several vaccinations are recommended to prevent hepatitis A, hepatitis B and human 
papillomavirus (HPV). 
•	 In	addition	to	traditional	testing	services	and	community	testing,	other	models	ought	to	be	considered	for	MSM	
who do not engage with services, for example, home testing and home sampling.
•	 Harm	reduction	interventions	for	alcohol	and	drugs	should	continue	to	be	supported	and	strengthened.
•	 Statutory	health	organisations	and	NGOs	should	continue	to	increase	awareness	of	sexual	consent	and	
negotiation, particularly for those engaging in chemsex. 
•	 Caregivers	involved	in	the	wellbeing	of	MSM	should	ensure	they	have	consistently	up-to-date	pathways	in	
place for referral in cases of substance misuse, drugs, alcohol and sexual abuse and that these are updated 
periodically. 
Future research 
Further research is required to qualitatively and quantitatively explore the results of EMIS-2017 Ireland. Further 
studies could consider the following areas:
•	 The	mental	health	of	MSM,	particularly	younger	MSM,	as	this	may	impact	on	the	general	health	and	wellbeing	
of MSM as well as their sexual health. It has been ten years since Supporting LGBT Lives was published 40, a 
similar national LGBT mental health survey would help further our understanding of this. 
•	 The	context	of	alcohol	consumption	among	MSM	and	the	association	of	alcohol	consumption	with	the	sexual	
and mental health of MSM. 
•	 Chemsex	including	
o demographic, behavioural factors and ill health associated with its use. This is important for the further 
development of information resources, support and referral pathways and infrastructure for those engaging 
in chemsex. Mental health aspects of chemsex, particularly in men where consent was compromised 
during chemsex.
o The effectiveness of providing party packs to men who engage in chemsex, particularly multiple partner 
chemsex, 
•	 The	causative	factors	behind	MSM	reporting	condomless	anal	intercourse	due	to	not	having	a	condom.
•	 The	profile	of	men	who	are	availing	of	PrEP	in	Ireland	and	why	they	use	PrEP.	This	research	could	also	
investigate the profile of men who are eligible for PrEP but not availing of it. This could help inform the planned 
roll-out of PrEP in Ireland. 
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•	 Research	with	MSM	who	identify	as	bisexual	or	who	are	having	regular	sex	with	women	is	warranted	as	they	
are an understudied population group who may have specific health and wellbeing needs.
•	 The	association	of	minority	stress	on	MSM	health	and	wellbeing	and	the	impact	minority	stress	has	on	access	
to care. 
•	 Men	who	are	not	born	in	Ireland	and	who	are	HIV	positive,	to	establish	if	they	are	receiving	treatment	for	HIV	
and their ability to access services. 
•	 A	latent	class	analysis	(analysis	of	subgroups)	of	EMIS-2017	Ireland	data	which	could	help	inform	health	
promotion and policy.
•	 A	formal	trend	analysis	across	EMIS-2010,	MISI-2015	and	EMIS-2017.	This	information	would	allow	for	the	
monitoring of national progress in sexual health and wellbeing of MSM in Ireland.
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Appendix A Comparisons between EMIS-2017 Ireland, 
MISI-2015 and EMIS-2010 Ireland 
EMIS-2010
EMIS-2010 was a multi-country, cross-sectional survey of MSM. It involved 38 countries, including Ireland.10  
A total of over 180,000 men were recruited, with Ireland contributing 2,303 respondents .The survey was available 
in 25 languages and was promoted using a number of dating websites where direct messages were sent to 
their members to complete the survey. In addition, promotional campaigns were organised in most participating 
countries via Facebook. The final report (including Irish specific data) can be found here: https://ecdc.europa.eu/
sites/portal/files/media/en/publications/Publications/EMIS-2010-european-men-who-have-sex-with-men-survey.
pdf. 
MISI-2015
MISI 2015 was a cross-sectional survey of MSM living in Ireland carried out in 2015 and included 3,090 men in the 
analysis.11 The survey was available in English only and was promoted on gay community and health promotion 
websites, through social media sites and promotional cards for social and community venues and services. To 
mark the start of the survey, a launch party was held and a press release was issued. The final report can be 
found here: https://www.hpsc.ie/a-z/specificpopulations/menwhohavesexwithmenmsm/msminternetsurvey2015/
misi2015reportandexecutivesummary/File,15696,en.pdf
EMIS-2010, MISI 2015 and EMIS-2017 data were independent, cross-sectional surveys and cannot be 
directly compared without accounting for differences in the ages of respondents, their country of birth, and 
recruitment methods in the different surveys. Any comparison of the reported prevalence of risks, behaviours and 
interventions needs to take these differences into consideration. 
Comparison of EMIS-2010, MISI 2015 and EMIS-2017 surveys
EMIS-20101 
n=2,303
MISI 20152 
n=3,090
EMIS-2017 
n=2,083
(%) (%) (%)
Demographic profile
Median age (years) 31 30 33
Respondents aged <25 years 24 31 23
Resides in Dublin 46 49 57
Living in a city >500,000 inhabitants 50 - 48
Born outside of Ireland 23 14 25
Unemployed 9 7 5
Steady relationship with a man 29 39 31
Steady relationship with woman 7 8 3
Identify as gay/homosexual 78 79 81
Out to all or almost all 40 51 51
1 Data taken directly from the EMIS 2010 report 
2 Data taken directly from the MISI 2015 report 
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Paid for sex in last 12 months 5 - 6
Been paid for sex in last 12 months 4 - 4
Reported ill health in MSM
Positive HIV diagnosis (whole sample) 6 5 7
Positive HIV diagnosis (among those tested) 10 8 9
Positive HIV diagnosis in last 12 months 3 1 1
Diagnosed any STI in last 12 months (whole sample)* 9 9 14
Diagnosed any STI among those tested in last 12 months 21 21 26
Syphilis diagnosis in last 12 months (whole sample) 2 - 3
Gonorrhoea diagnosis in last 12 months (whole sample) 2 - 9
Chlamydia diagnosis in last 12 months (whole sample) 3 - 6
First diagnosis of anal/genital warts in last 12 months 3 - 1
Risk and precautionary behaviour
Currently on ART (for those HIV positive) 75 79 94
Ever used PEP (for those not HIV positive) - 4 10
Currently use PrEP (either daily or event-based) (for those not HIV 
positive)
- 2 4
Ever had anal intercourse with a man (among men who had sex with 
men)
94 88 93
Sex with women in last 12 months 14 14 9
CAI with a steady male partner in last 12 months (among men who 
had sex with a steady partner in the last 12 months)
66 68 75
CAI with a non-steady male partner last 12 months (among men who 
had sex with a non-steady partner in the last 12 months)
40 42 55
History of drug injecting (drugs and/or anabolic steroids)† 3 2 4
% Alcohol consumed in last 24hrs‡ 41 - 40
% Tobacco consumed in last 24 hours‡ 36 - 26
% Poppers use in last 12 months◆ - 33 46
% Cannabis use in last 12 months◆ - 28 34
% Ecstasy use in last 12 months◆ - 17 19
% Cocaine use in last 12 months◆ - 13 20
Needs
Internalised homonegativity score (average) 2 - 1
CAI because no condom in last 12 months 16 16 27
Concerned about drug use (among men who took drugs in the last 12 
months)
6 - 8
Interventions
Verbally insulted in last 12 months because someone knew/thought 
you were attracted to men
33 - 28
Accessed free condoms last 12 months - 39 56
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Seen HIV/STI information specifically for MSM in last 12 months 85 - 91
Never tested for HIV 37 37 23
HIV ever monitored - 99 100
HIV monitored in the past 6 months 93 93 99
Receiving ART (among those whose HIV was monitored past 6 
months)
75 85 95
Undetectable viral load (among those on ART) 80 91 97
Full course of hepatitis B vaccination 48 - 53
STI test in last 12 months 38 39 55
*Any STI in MISI 2015 and EMIS-2017 was defined as syphilis, gonorrhoea and/or chlamydia. EMIS-2010’s definition is not clear and may 
include all of the above and anal/genital warts. 
† EMIS-2010 only asked about self-injecting. MISI 2015 and EMIS-2017 asked about self-injecting or someone injected you. 
‡ MISI 2015 asked about daily use of alcohol and tobacco. EMIS-2010 and 2017 asked about alcohol and tobacco consumption in the last 
24 hours. 
◆ MISI 2015 respondents were asked to tick from a list of drugs they had used in the last 12 months. EMIS-2010 and 2017 asked about 
each drug separately and asked about their recency of use (i.e. last 24 hours, last 6 months, last 12 months, ever). Ecstasy use in EMIS-2017 
refers to ecstasy pills.
Percentages are rounded in the table.

